The QualityStocks Daily Thursday, May 9th, 2019

Today's Top 3 Investment Newsletters

StockMarketWatch (CTRL) +39.60%

CannabisNewsWire (THRM) +33.33%

The Street (ROKU) +28.11%

The QualityStocks Daily Stock List

Westleaf, Inc. (WSLFF)

Stock Target Advisor, Midas Letter, InvestorsHub, Technical420, Business Insider, Barchart, Investor Ideas, Insider Financial, Pinnacle Digest, Wallmine, Trading View, Stockwatch, MarketWatch, Stockhouse, YCharts, Morningstar, and Investors Hangout reported earlier on Westleaf, Inc. (WSLFF), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.

Westleaf, Inc. engages in the cultivation, extraction, distribution, and sale of cannabis and cannabis related products. The Company is a vertically integrated cannabis business. It has assets owned and under development across cultivation, extraction, processing, manufacturing, and wholly-owned retail. Westleaf is based in Calgary, Alberta and lists on the OTC Markets' OTCQB.

Westleaf is developing a national presence of retail stores called Prairie Records. This is a brand that celebrates the instinctual tie between music and recreational cannabis. Prairie Records provides access to the nation's best cannabis. It is a reinvention of the cannabis purchasing experience in a high design, sophisticated retail space, reflecting that of a modern record store.

The Company's brands also include Loon Cannabis and Westleaf Cannabis. Loon Cannabis is a health and wellness cannabis line. The design of it is to help customers live their optimal lives, so they can thrive and enjoy life with clarity and peace of mind. Loon Cannabis has an assortment of calming strains and inventive products.

Westleaf Cannabis created a signature brand of medicinal cannabis products for customers looking to treat symptoms of illness and other conditions. The design of these products is to help customers reduce pain or to moderate side effects from ongoing health conditions.

Westleaf has launched its e-commerce site for sales across the entire Province of Saskatchewan. The retail site, at www.prairierecords.ca, provides consumers in Saskatchewan convenient online access to a wide array of products through the innovative Prairie Records retail concept, which combines music and cannabis in an engaging online experience.

Prairie Records centers solely on densely populated neighborhoods, high traffic areas, as well as tourist destinations. The foundation of the retail concept is ingrained with a desire to create a unique cannabis buying experience through tactile in-store features and product offerings celebrating the relationship between music and cannabis.

Last month, Westleaf announced it exercised its earlier announced option to purchase all of the issued and outstanding shares of 102053012 Saskatchewan Ltd. (102), which operates a cannabis retail store located at 720 Broadway Avenue, Saskatoon. In addition, Westleaf announced it exercised its earlier announced option to purchase all of the issued and outstanding shares of 102053592 Saskatchewan Ltd. (592), which operates a cannabis retail store located at 170-3020 Preston Avenue, Saskatoon.

Westleaf, Inc. (WSLFF), closed Thursday's trading session at $0.5072, up 0.34%, on 106,720 volume with 62 trades. The average volume for the last 3 months is 117,144 and the stock's 52-week low/high is $0.472/$5.00.

chart

Research Solutions, Inc. (RSSS)

Zacks, Street Insider, Simply Wall St, Wallet Investor, Market Screener, MarketWatch, InvestorsHub, Seeking Alpha, Capital Cube, and 4-Traders reported previously on Research Solutions, Inc. (RSSS), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Research Solutions, Inc. is a provider of workflow efficiency solutions for R&D-driven organizations in life sciences, technology, as well as academia globally. The Company's Software-as-a-Service (SaaS) platform provides tools or "Gadgets" that allow users to discover, access, manage and collaborate around science, technology and medical (STM) content and data. OTCQB-listed, Research Solutions is headquartered in Encino, California.

The Company's customers range from 70 percent of the top 25 global pharmaceutical companies to emerging small and medium-sized businesses. Research Solutions produces recurring revenue from subscriptions to its SaaS platform and transactional revenue from the sale of STM content. The Company's wholly-owned subsidiary is Reprints Desk.

In essence, Research Solutions, via its subsidiaries, provides annual licenses. These allow customers to access and utilize features of a cloud based SaaS research intelligence platform. Additionally, the Company engages in the transactional sale of published scientific, technical, and medical content managed, sourced, and delivered through the Transactions platform. Its solutions enable life science and other research intensive organizations to expedite research and development (R&D) activities with single sourced access and management of content and data used in the intellectual property (IP) development lifecycle.

Recently, Research Solutions and its wholly-owned subsidiary Reprints Desk announced the addition of the Reference Manager Gadget to its Article Galaxy platform. A single-source solution, Reference Manager is now available in the Article Galaxy Gadget Store. Reference Manager combines scientific search and discovery, on-demand access to full-text scholarly articles, and strong bibliographic reference management into one integrated application. Reference Manager offers intelligent management of personal and group bibliographies with integrated discovery and copyright-managed PDF collections to individual researchers and enterprises.

Mr. Peter Derycz, Research Solutions' President and Chief Executive Officer, said, "Our mission to help scientists personalize their research and improve the discovery process continues with the release of our Reference Manager Gadget. This game-changing app for one-stop reference and literature management reduces the time-consuming and laborious nature of scientific research. At Reprints Desk, we're enthusiastic about helping researchers accelerate science."

Research Solutions will hold a conference call on Wednesday, May 15, 2019, at 5:00 p.m. Eastern time to discuss its financial results for the fiscal Q3 ended March 31, 2019. Financial results will be issued in a press release before the call.

Research Solutions, Inc. (RSSS), closed Thursday's trading session at $2.45, up 10.36%, on 7,200 volume with 13 trades. The average volume for the last 3 months is 2,180 and the stock's 52-week low/high is $1.50/$2.70.

chart

CV Sciences, Inc. (CVSI)

Micro Small Cap, Zacks, CannabisMarketCap, Micro Cap Daily, Super Stock Screener, Daily Marijuana Observer, StreetWise Reports, Analyst Ratings, Infront Analytics, Insider Tracking, MarketWatch, Proactive Investors, InvestorsHub, Stockhouse, Barchart, New Cannabis Ventures, Simply Wall St, and 4-Traders reported previously on CV Sciences, Inc. (CVSI), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

OTCQB-listed, CV Sciences, Inc. operates as a life science company. It operates two distinct business segments - a Consumer Products Division and a Drug Development Division. The Company's PlusCBD Oil is the top-selling brand of hemp-derived CBD on the market, according to SPINS, the foremost provider of syndicated data and insights for the natural, organic and specialty products industry. CV Sciences has main offices and facilities in San Diego, California and Las Vegas, Nevada.

CV Sciences' Consumer Product division focuses on manufacturing, marketing and selling hemp-based CBD products to a range of market sectors. The Consumer Products Division delivers botanical‐based cannabidiol products. At present, these are distributed nationally in health food stores, health care provider's offices, and also online.

The Drug Development division focuses on developing and commercializing novel therapeutics utilizing CBD (cannabidiol). This Division is developing synthetically‐formulated cannabidiol‐based medicine, pursuing the approval of the U.S. Food and Drug Administration (FDA) for drugs with specific indications using cannabidiol as the active pharmaceutical ingredient. CV Sciences states that it has attained promising preclinical results in the development of cannabinoid medicines for the treatment of an array of medical conditions.

Last month, CV Sciences announced more expansion of its PlusCBD Oil™. As of March 31, 2019, PlusCBD Oil™ branded products are available in 3,308 retail stores. This is up 48 percent from 2,238 retail stores as of December 31, 2018. The expansion includes widening distribution of its best-selling topical, PlusCBD Oil™ Extra Strength Balm, into the Food, Drug and Mass (FDM) channel, including programs with top national retailers.

CV Sciences achieved record Revenue of $14.9 million for Q1 of 2019. This represents an increase of 85 percent over the same quarter in 2018. The Company had a Gross Margin of 70.8 percent versus a Gross Margin of 68.9 percent in Q1 of 2018.

CV Sciences, Inc. (CVSI), closed Thursday's trading session at $4.87, down 2.60%, on 2,539,129 volume with 3,424 trades. The average volume for the last 3 months is 1,064,563 and the stock's 52-week low/high is $0.74/$9.19.

chart

FLYHT Aerospace Solutions Ltd. (FLYLF)

Wallmine, TipRanks, Wallet Investor, Stockhouse, Stockwatch, and Invest Tribune reported earlier on FLYHT Aerospace Solutions Ltd. (FLYLF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

FLYHT Aerospace Solutions Ltd. provides real-time aircraft intelligence and cockpit communications for the aerospace industry. The Company's mission is to improve aviation safety, efficiency and profitability. It offers its differentiated aircraft and enterprise-based solutions to deliver real-time, flight-deck, satellite connectivity for tracking, health monitoring, and streaming of operational, maintenance and weather data. FLYHT Aerospace Solutions has its corporate office in Calgary, Alberta. It also has an office in Littleton, Colorado. The Company's shares trade on the OTCQX.

Airlines, leasing companies, fractional owners and original equipment manufacturers (OEMs) install FLYHT Aerospace Solutions' differentiated aircraft and enterprise-based solutions. Fundamentally, FLYHT is a foremost provider of Iridium satellite communications, global flight tracking including live FDR streaming capabilities, and aircraft health monitoring solutions.

Its Automated Flight Information Reporting System (AFIRS™) is specifically designed to enhance operational control, improve dispatch reliability and safety and lessen costs. The Automated Flight Information Reporting System (AFIRS™) is an Iridium-based SATCOM device installed on the aircraft that uses FLYHT's proprietary software to acquire and transmit aircraft data to the ground in real time, where it is subsequently processed and distributed to the customer using FLYHT's ground server network named UpTime™.

FLYHT Aerospace Solutions has an international presence with sales and installation support in China, South East Asia, the U.S. and Europe. The Company was presented the Excellence in Avionics Safety Systems Innovation Award from Avionics Magazine, presented at the Global Connected Aircraft Summit in 2015. FLYHT was also recognized with an Alberta Export Award in the Advancing Technologies Category, November 2011.

In April, FLYHT Aerospace Solutions announced receipt of a new US$1.8 million purchase order for Iridium modems and license fees. The complete purchase order is scheduled to be shipped within 2019 for the two certified aircraft platform types attained through this agreement. Moreover, the value of the order slightly exceeds the total revenue gained from modem and license shipments to this customer for these platforms last year.

FLYHT Aerospace Solutions Ltd. (FLYLF), closed Thursday's trading session at $1.138, up 5.30%, on 6,484 volume with 7 trades. The average volume for the last 3 months is 5,559 and the stock's 52-week low/high is $0.67/$1.239.

chart

Lynas Corporation Limited (LYSDY)

Zacks, Investor Intel, Street Insider, 4-Traders, Teletrader, Dividend Investor, Wallet Investor, MarketWatch, Stockhouse, Pink Investing, Marketbeat, Morningstar, GuruFocus, Trading View, and Equity Clock reported earlier on Lynas Corporation Limited (LYSDY), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Lynas Corporation Limited, together with its subsidiaries, engages in the exploration, development, mining, extraction, and processing of rare earth minerals mainly in Australia and Malaysia. The Company is an integrated source of rare earths from mine to customer. Its resource deposit in Mt Weld, Western Australia, is acknowledged as one of the highest grade rare earths mine globally. Lynas has its head office in Kuantan, Malaysia.

The Company's rare earth oxides are mined and initially processed at its Mt Weld Concentration Plant. The materials are subsequently shipped to the industrial port in Kuantan, Malaysia, and transported to Lynas' 100 hectare Lynas Advanced Materials Plant (LAMP) in Kuantan. At LAMP, Lynas undertakes a complex series of refining and concentration operations to produce high quality rare earth minerals.

The LAMP was granted a Full Operational Stage License (FOSL) from Malaysia's Atomic Energy Licensing Board (AELB) on September 2, 2014. The LAMP is currently supplying rare earths products to customers in Japan, China, Vietnam, South Korea, Europe and North America. Lynas' Japanese customer base continues to grow and now represents roughly 60 percent of sales.

In addition, Lynas produces and supplies neodymium-praseodymium material. Moreover, the Company offers corporate services. Lynas' Mt Weld is situated 35km south of Laverton in Western Australia. The Mt Weld Concentration Plant was commissioned in 2011 and is located 1.5km from the mine site.

On April 26, 2019, Lynas Malaysia announced it received two awards that week. One was recognition for assisting the Fire and Rescue Department of Malaysia during the recent fires in the Gebeng area. The other was a Malaysia Best Employer Brand Award 2019. ​ The Company noted that these awards are evidence of Lynas Malaysia's continuing positive commitments to its communities and employees and more evidence of its commitment to fulfill all its duties as an excellent Foreign Direct Investor.

Last month, Lynas reported a 32.5 percent rise in production of rare earths oxides during the quarter. Output of rare earths oxides (REO) in the quarter ending March 31 was 5,444 tonnes, versus 4,110 tonnes produced last year. Production of NdPr, or neodymium-praseodymium, increased 19.4 percent to 1,591 tonnes, a new quarterly record. Q3 Sales Revenue increased almost 18 percent to A$101.3 million.

Lynas Corporation Limited (LYSDY), closed Thursday's trading session at $1.30, up 4.84%, on 8,431 volume with 5 trades. The average volume for the last 3 months is 19,708 and the stock's 52-week low/high is $1.054/$2.079.

chart

Predictive Technology Group, Inc. (PRED)

NetworkNewsWire, StreetWise Reports, Zacks, InvestorsHub, Insider Financial, Wallet Investor, Wallmine, Infront Analytics, The Street, Dividend Investor, Simply Wall St, and Stockhouse reported previously on Predictive Technology Group, Inc. (PRED), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Predictive Technology Group, Inc. is a therapeutics and life sciences company listed on the OTC Markets. It is a leader in the use of data analytics for disease identification and subsequent therapeutic intervention via innovative novel gene-based diagnostics, biotechnology treatments and companion therapeutics. The Company previously went by the name Global Enterprises Group, Inc. It changed its name to Predictive Technology Group, Inc. in July of 2015. Predictive Technology Group is based in Salt Lake City, Utah.

The Company's wholly-owned subsidiaries are Predictive Therapeutics and Predictive Biotech. Through these, it concentrates on four primary clinical categories: Endometriosis, Scoliosis, Degenerative Disc Disease and Regenerative Human Cell and Tissue Products. Predictive Laboratories centers on clinical and discovery work for human infertility and genetic conditions affecting women and children. Testing is performed using state-of-the-art instrumentation at its CAP and CLIA accredited facility.

Further to Predictive Biotech's efforts to advance regenerative medicine, Predictive Therapeutics is committed to assisting women in overcoming the devastating consequences of endometriosis through appropriate early-stage diagnosis and subsequent treatment.

Subsidiary Predictive Biotech is a leader in human cell and tissue products for use in regenerative medicine. A growing national network of clinics, health systems, researchers and physicians leverage Predictive Biotech's four chief placental-derived and Wharton's jelly umbilical cord-derived products (AmnioCyte™, AmnioCyte Plus™, PolyCyte™, CoreCyte™).

This week, Predictive Technology Group announced its wholly-owned subsidiary Predictive Laboratories reached an enrollment milestone of 200 participants in its continuing Institutional Review Board (IRB)-approved study of spine and joint disease leading to chronic pain. Predictive Laboratories is the sponsor of the study. Kenneth Ward, MD, Laboratory Director of Predictive Laboratories, serves as Principal Investigator.

The main goal of the IRB study is to conduct genetic research related to healthcare advancement in the diagnosis, treatment and prevention of conditions causing chronic pain. The first 200 participants have volunteered for the study by submitting their DNA samples to the Predictive Biorepository and by reporting detailed medical information via their healthcare providers.

Today, Predictive Technology Group announced Board of Director Committee Chair appointments. The Company's Board of Directors, at its quarterly board meeting held May 8, 2019, finalized important committee appointments. Predictive Chairman of the Board John Sorrentino announced that the Audit Committee and Compliance Committee Chair is Jay Moyes; the Nominating Committee Chair is John Sorrentino; and the Compensation Committee Chair is Ron Barhorst.

                   

Predictive Technology Group, Inc. (PRED), closed Thursday's trading session at $3.90, up 18.90%, on 652,785 volume with 835 trades. The average volume for the last 3 months is 254,259 and the stock's 52-week low/high is $0.77/$3.90.

chart

Saker Aviation Services, Inc. (SKAS)

InvestorsHub, Zacks, Marketbeat, Stock Invest, Investors Hangout, Stockhouse, Trading View, GlobeNewswire, YCharts, Market Screener, Equity Clock, and Wallet Investor reported earlier on Saker Aviation Services, Inc. (SKAS), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Saker Aviation Services, Inc., by way of its subsidiaries, operates in the aviation services segment of the general aviation industry in the United States. The Company has locations in the Northeast and Midwest. Saker Aviation Services serves as the operator of a heliport, a fixed base operation (FBO); a provider of aircraft maintenance and repair services (MRO); and a consultant for a seaplane base. The Company lists on the OTC Markets Group's OTCQB. It previously went by the name FirstFlight, Inc. It changed its corporate name to Saker Aviation Services, Inc. in September of 2009. Saker Aviation Services has its corporate headquarters in New York, New York.

In addition, the Company provides ground-based services, including fueling and aircraft storage for general aviation, commercial, and military aircraft, as well as other miscellaneous services. Saker's business activities are carried out as the operator of the Downtown Manhattan (New York) Heliport; as an FBO and MRO at the Garden City (Kansas) Regional Airport; and as a consultant to the operator of a seaplane base in New York City.

Furthermore, Saker Aviation Services is an Avfuel branded dealer. Avfuel Corporation is the nation's foremost independent supplier of aviation fuels and services. Saker Aviation participates in Avfuel Contract Fuel Programs.

Pertaining to Charters, Saker's Charter Sales staff helps one arrange their trip based on their personal preferences. Saker will customize one's aircraft management program to meet their unique goals. The Company has an experienced maintenance, concierge, as well as charter staff.

Recently, Saker Aviation Services announced its financial results for the twelve months ended December 31, 2018. Revenue and Net Income in the twelve months ended December 31, 2018 of $11,118,452 and $311,536, respectively, were down 7.5 percent and 34.8 percent, respectively, versus Revenue of $12,016,031 and $477,628 in the twelve months ended December 31, 2017.

Saker Aviation Services, Inc. (SKAS), closed Thursday's trading session at $3.85, up 12.90%, on 559 volume with 6 trades. The average volume for the last 3 months is 1,236 and the stock's 52-week low/high is $2.04/$4.50.

chart

General Cannabis Corp. (CANN)

Zacks, InvestorsHub, Green Rush Review, Stockwatch, OTC Markets, Marijuana Stocks, CannabisMarketCap, Micro Small Cap, Trading View, Wallet Investor, The Street, Infront Analytics, Micro Cap Daily, Simply Wall St, Pot Stock News, StreetWise Reports, MarketWatch, Tmxmoney, Barchart, Insider Financial, Stockhouse, Daily Marijuana Observer, and Central Charts reported earlier on General Cannabis Corp. (CANN), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

OTCQX-listed, General Cannabis Corp. is the comprehensive national resource for the highest quality service providers available to the regulated cannabis industry. The Company is a trusted partner to the cultivation, production, as well as retail sides of the cannabis business. General Cannabis has strong operating divisions, including real estate, consulting, security, financing and the distribution of important infrastructure products to grow facilities and dispensaries. The Company is headquartered in Denver, Colorado.

General Cannabis' family of brands include Next Big Crop (NBC), Chiefton, and Iron Protection Group (IPG). Its NBC offers premier management and consulting services. NBC deploys proven solutions for every phase of medical and adult-use cannabis business operations. This is from licensure, design and construction, to the cultivation, manufacture and sale of medical-grade cannabis product.

Chiefton works to provide eco-friendly apparel, accessories, and printing techniques. It creates mainstream relevant cannabis lifestyle brands. Chiefton's apparel and accessories use textiles like hemp, organic cotton, and recycled polyester that deliver performance, comfort, and accountability. Furthermore, Chiefton uses Denver's only certifiably green screen-printing shop.

Moreover, General Cannabis' IPG is one of the fastest-growing security companies in the nation. IPG's operators are US Veterans. They are vigilant about education pertaining to regulations to ensure that compliance permeates every element of its clients' business.

Recently, General Cannabis announced it hired apparel and manufacturing veteran Mr. David Hirst to lead Chiefton Supply's (Chiefton) growth efforts in the thriving cannabis-inspired lifestyle apparel space. Most recently serving as Vice President of Sales for Outward Hound, Mr. Hirst has greater than two decades of senior-level sales, business development and marketing experience across sporting and outdoor goods and apparel. His wide-ranging background includes more than 12 years with Jarden Outdoor Solutions (now Newell Brands) where he worked with international brands including K2 Sports and The Coleman Co.

Last month, General Cannabis announced an investment in Consolidated C.R., LLC (CCR), a Puerto Rico Limited Liability Company (LLC). The Company is investing $375,000 in the form of a convertible promissory note, bearing interest at 12 percent, collateralized by virtually all of the assets of CCR, with a term of 18 months. General Cannabis has a 90 day option to convert $250,000 of principal under the note into a 10 percent equity ownership in CCR. Located in San Juan, Puerto Rico, CCR is a vertically integrated medical cannabis company.

General Cannabis Corp. (CANN), closed Thursday's trading session at $1.71, even for the day, on 133,081 volume with 188 trades. The average volume for the last 3 months is 179,806 and the stock's 52-week low/high is $1.46/$4.51.

chart

Dyadic International, Inc. (DYAI)

Proactive Investors, Marketbeat, Market Screener, Wallmine, OTC Markets, Value Investors Club, Investors Hub, Zacks, Stockhouse, Equity Clock, Wallet Investor, Stockopedia, Uptick Newswire, and GuruFocus reported earlier on Dyadic International, Inc. (DYAI), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Dyadic International, Inc. is an international biotechnology company based in Jupiter, Florida. It focuses on further improving and applying its proprietary C1 gene expression platform. The Company is developing what it believes will be a potentially significant biopharmaceutical gene expression platform founded on the fungus Myceliophthora thermophila, called C1.

The C1 microorganism enables the development and large scale manufacture of low cost proteins. It has the potential to be further developed into a safe and efficient expression system, which may help accelerate the development, lower production costs and improve the performance of biologic vaccines and drugs at flexible commercial scales.

Dyadic International is using the C1 technology and other technologies to conduct research, development and commercial activities for the development and manufacturing of human and animal vaccines and drugs (including virus like particles (VLPs) and antigens), monoclonal antibodies, Fab antibody fragments, Fc-Fusion proteins, biosimilars and/or biobetters, and other therapeutic proteins.

Furthermore, the Company more recently is also starting to explore the use of its C1 technology and other technologies to conduct research, development and commercial activities for the development and manufacturing of Adeno-associated viral vectors (AAV) and certain metabolites.

Recently, Dyadic International announced its financial results for the year ended December 31, 2018, and recent developments. The Company had nine funded proof of concept research collaborations signed in 2018 and two new collaborations in 2019. Improved scientific data was generated. This reflects strong C1 capabilities and new attributes. Research and development Revenue for the year ended December 31, 2018, increased to roughly $1,295,000 versus $758,000 for the year ended December 31, 2017.

Mr. Mark Emalfarb, Dyadic International's Chief Executive Officer, said, "2018 was another year of continued progress with many favorable milestones. I am very pleased to report that we have signed nine funded research collaborations in 2018, including Sanofi-Aventis, and Mitsubishi Tanabe Pharma, which we previously announced, a collaboration with a top twenty pharmaceutical company in Q4 2018. In the first quarter of 2019, we signed two new research collaboration agreements both with top twenty-five pharmaceutical companies. These programs demonstrate that the market and the industry are taking notice of Dyadic and the perceived capability of our C1 gene expression platform."

Recently, Dyadic International announced that its common stock was approved to list on The Nasdaq Capital Market. The expectation is that trading on the Nasdaq will begin on or about April 17, 2019 under the trading symbol DYAI.

Dyadic International, Inc. (DYAI), closed Thursday's trading session at $3.90, up 9.86%, on 184,042 volume with 654 trades. The average volume for the last 3 months is 65,113 and the stock's 52-week low/high is $1.39/$4.06.

chart

Generex Biotechnology Corporation (GNBT)

Stock Twits, Stockhouse, Capital Cube, Investors Hangout, Infront Analytics, Simply Wall St, Biospace, Business Wire, Zacks, Stockwatch, Marketbeat, Baystreet.ca, Dividend Investor, GuruFocus, Insider Financial, InvestorsHub, GlobeNewswire, Market Screener, Trading View, Last10k, MarketWatch, Equity Clock, and Insider Tracking reported earlier on Generex Biotechnology Corporation (GNBT), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Generex Biotechnology Corporation is an integrated healthcare holding company listed on the OTCQB. It has end-to-end solutions for patient centric care from swift diagnosis through delivery of personalized therapies. The Company is building a new kind of healthcare company, which extends beyond traditional models providing support to physicians in an MSO network, and continuing relationships with patients to improve the patient experience and access to optimum care. Generex Biotechnology is based in Miramar, Florida.

The Company's newly formed, wholly-owned subsidiary is NuGenerex Distribution Solutions (NDS). It integrates the Company's MSO network with a pharmacy network, clinical diagnostic lab, durable medical equipment company (DME-IQ) and dedicated call center.

Generex Biotechnology's corporate mission is to provide physicians, hospitals, and healthcare providers an end-to-end solution for patient centric care This is from fast diagnosis through delivery of personalized therapies, streamlining care processes, minimizing expenses, and delivering transparency for payers.

Generex Biotechnology is advancing a legacy portfolio of immune-oncology assets, medical devices, as well as diagnostics. Nonetheless, it is concentrating on an acquisition strategy of strategic businesses, which complement existing assets and provide immediate sources of revenue and working capital. Its recent acquisitions include a management services organization, a network of pharmacies, clinical laboratory, and medical device companies with new and approved products.

Last week, Generex Biotechnology announced the appointment of Mr. Mark J. Prioletti to the Board of Directors. Mr. Prioletti is a highly experienced marketing and business professional. He has greater than 35 years of success in the wireless communications industry for government, enterprise, and consumer segments in the United States and worldwide markets.

Mr. Prioletti had a distinguished career at Motorola, leading Channel Marketing & Sales, New Program Development, Partnership and Alliance Development to significantly expand the Motorola sales operations that continually generated profitable revenue and growth for developing markets and mature businesses. Mr. Prioletti has exceptionally strong skills in marketing strategy and sales operation.

Generex Biotechnology Corporation (GNBT), closed Thursday's trading session at $1.10, down 0.90%, on 40,426 volume with 36 trades. The average volume for the last 3 months is 63,044 and the stock's 52-week low/high is $0.088/$3.09.

chart

Auto Trader Group plc (ATDRY)

Penny Stock Tweets, Stock Digest, Penny Stock Hub, Stock Scores, Wallmine, Marketbeat, Market Screener, Stockopedia, Zacks, Barchart, Street Insider, Wallet Investor, Dividend Investor, Investors Hangout, GuruFocus, Morningstar, YCharts, MarketWatch, and The Street reported earlier on Auto Trader Group plc (ATDRY), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Established in 1977, Auto Trader Group plc operates in the digital automotive marketplace in the United Kingdom (UK) and Ireland. The Company offers its products to retailers and home traders, and logistics firms. It also offers vehicle advertisement on its Websites for private sellers. In addition, it offers insurance and loan financing products to consumers and display advertising on its Websites for manufacturers and their advertising agencies.

Auto Trader Group lists on the OTC Markets. The Company has its corporate office in Manchester, UK. The Company was 32nd in the Sunday Times Best Companies to Work For 2018.

Auto Trader is a 100 percent digital business. In 2013, the Company successfully completed the transition from a print title and became a completely digital marketplace. Of note is that 94 advert views every second take place on its site.

Auto Trader Group is the UK's largest digital automotive marketplace. The Company has greater than 90 percent prompted brand awareness with consumers. Auto Trader Group attracts circa 55 million cross platform visits monthly. Moreover, 70 percent of these visits come through mobile devices. More than 80 percent of UK automotive retailers advertise on autotrader.co.uk.

Furthermore, 450k cars are listed on Auto Trader at any one time and the web portal is the 12th biggest website in the UK. Auto Trader has a 3x larger consumer audience versus its nearest competitor. It is the No.1 trusted automotive classified brand in the UK. In addition, 93 percent of UK consumers know who Auto Trader Group is.

For car buyers, Auto Trader Group has added pricing indicators to signal the best priced vehicles. For retailers and manufacturers, the Company added a Premium level for retailers wanting to grow faster. Auto Trader Group's corporate mission is to lead the digital future of the UK automotive marketplace.

Auto Trader Group plc (ATDRY), closed Thursday's trading session at $1.90, up 1.06%, on 95,406 volume with 47 trades. The average volume for the last 3 months is 267,575 and the stock's 52-week low/high is $1.17/$1.92.

chart

AMMO, Inc. (POWW)

Infront Analytics, Simply Wall St, GlobeNewswire, GuruFocus, Morningstar, Wallet Investor, YCharts, Barchart, The Street, Stockopedia, Stockwatch, Dividend Investor, Stockhouse, 4-Traders, InvestorsHub, Stockawiki, Investors Hangout, Business Insider, Market Screener, Trading View, MarketWatch, and Seeking Alpha reported previously on AMMO, Inc. (POWW), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

AMMO, Inc. is a technology leader and premier American ammunitions manufacturer listed on the OTC Markets' OTCQB. The Company designs and manufactures products for an array of aptitudes. This includes law enforcement, military, hunting, sport shooting and self-defence. Established in 2016, AMMO has its corporate office in Scottsdale, Arizona. AMMO operates a munitions manufacturing facility in Payson, Arizona, and a brass casings manufacturing facility in Manitowoc, Wisconsin.

The Company promotes branded munitions. These include its patented STREAK™ Visual Ammunition, the Jesse James line of munitions and accessories, /stelTH/ subsonic munitions, O.W.L. Technologies®, TAC-PTM Tactical Precision Defense munitions, and OPS (One Precise Shot). OPS is a lead-free frangible tactical line of munitions for self-defence.

The ammunition the Company builds performs like high end custom hand loaded ammunition. AMMO works to be the foremost innovator of center-fire ammunition for military, law enforcement, and civilians. Every load is developed for a specific purpose.

The emphasis is on consistency, accuracy, and, in some cases, felt recoil. Each round is designed, manufactured, inspected and packaged to bring a premier shooting experience to AMMO's end consumer. Moreover, the Company's HyperClean technology enables its customers to shoot more and clean less.

Recently, AMMO announced that the rollout of its STREAK™ Visual Ammunition product line to 142 Bass Pro Shops and Cabela's locations is complete. AMMO also announced that its STREAK products will be featured in an upcoming Bass Pro Shops national ad campaign and within their renowned retail catalogs.

In March, AMMO announced it closed the strategic acquisition of Jagemann Sporting Group's Wisconsin Casings division (Jagemann Casings). Jagemann's Casing Division is located in Manitowoc Wisconsin, the headquarters for Jagemann Stamping, the 73-year-old parent company established to serve the automotive industry with specialty precision metal stamped parts. The Jagemann Casings operations will continue to be led by its present general manager and an established manufacturing team that will manage the business and operations under the direction of AMMO, Inc.

The manufacturing operations will remain in Manitowoc, Wisconsin. Jagemann Chief Executive Officer, Mr. Tom Jagemann, will continue to lead Jagemann Stamping Company and concentrate on its core business as a foremost manufacturer of deep drawn, progressive and fine blanking metal stampings. Mr. Jagemann has been appointed as a Director on AMMO, Inc.'s Board in conjunction with the closing of the transaction.

In March, AMMO was awarded its first U.S. Law Enforcement contract within its home state of Arizona. Under the contract, IT will be supplying its "AMMO Branded" ammunition to include pistol and certain calibers of rifle rounds.

AMMO, Inc. (POWW), closed Thursday's trading session at $2.70, up 0.75%, on 6,239 volume with 6 trades. The average volume for the last 3 months is 8,675 and the stock's 52-week low/high is $1.50/$6.50.

chart

Body and Mind, Inc. (BMMJ)

MicroSmallCap, Penny Stock Tweets, Dividend Investor, Wallmine, Market News Updates, PotStockNews, Investor Ideas, Stockhouse, New Cannabis Ventures, Wallet Investor, Trading View, Simply Wall St, The Street, Barchart, InvestorsHub, Insider Financial, Morningstar, Midas Letter, Canadian Insider, and GuruFocus reported on Body and Mind, Inc. (BMMJ), and today we choose to highlight the Company, here at the QualityStocks Daily Newsletter.

Body and Mind, Inc. invests in high quality medical and recreational cannabis cultivation, production and retail. The Company's wholly-owned Nevada subsidiary was awarded one of the first medical marijuana cultivation licences. In addition, it holds cultivation and production licenses. Body and Mind (BaM) products include dried flower, edibles, topicals, extracts, and GPEN Gio cartridges. The Company lists on the OTC Markets and is based in Vancouver, British Columbia.

Body and Mind's cannabis plants are grown with hands-on care in small batches. Moreover, the Company never uses synthetic pesticides. It offers an assortment of strains, available in flower, vapes, pre-rolls and concentrates. Body and Mind has collected, for several years', elite cannabis plants from all over the world. Through carefully crossbreeding these plants, the Company has developed strains that give what it states are the perfect balance of body and mind benefits.

This past February, Body and Mind announced that the Clubhouse dispensary in Ohio received final approvals from the Ohio Board of Pharmacy and Elyria City Council to open the dispensary on February 22, 2019. Nevada Medical Group LLC (NMG Nevada), a wholly-owned subsidiary of the Company, recently entered into a definitive agreement where NMG Nevada will acquire 100 percent ownership of NMG Ohio LLC.

NMG Nevada, which previously held a 30 percent interest in NMG Ohio, will purchase the remaining 70 percent interest for fair value consideration of USD $3,150,000. NMG Ohio owns a dispensary in Loraine County, Elyria and a production license.

In addition, last month, Body and Mind announced expansion into Arkansas with in-State partner, Comprehensive Care Group LLC (CCG). The companies will work together to develop a medical marijuana dispensary facility in West Memphis, Arkansas. Medical marijuana dispensaries in Arkansas are licensed for retail sales and cultivation of up to 50 plants within the same facility.

Mr. Robert Hasman, director of the Company, said, "We are pleased to have been successful in assisting Comprehensive Care Group obtain a dispensary license through the application process, an initiative that creates significant value for all stakeholders. Secondly, this deal provides BaM shareholders greater retail exposure, a fourth platform for growth and a path to launch some of its' own products to the medical patients of Arkansas. We are proud to have been selected as one of only 32 dispensary licenses awarded in Arkansas and look forward to working with Comprehensive Care Group."

Body and Mind, Inc. (BMMJ), closed Thursday's trading session at $1.8959, up 8.34%, on 255,877 volume with 373 trades. The average volume for the last 3 months is 446,016 and the stock's 52-week low/high is $0.25/$2.70.

chart

Eurosport Active World Corp. (EAWD)

Wall Street Analyzer, Penny Stock Tweets, Marketwired, Pink Investing, Stockopedia, Investors Hangout, Street Insider, Stockhouse, MarketWatch, InvestorsHub, Plunkett Research, The Street, Simply Wall St, Market Screener, Wallet Investor, and Dividend Investor reported earlier on Eurosport Active World Corp. (EAWD), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.

EAWC Technologies (EAWC) (also known as Eurosport Active World Corp.) is an engineering services company listed on the OTC Markets. It formed as an outsourcing services green technology platform that can provide a comprehensive services package to measure the feasibility of the potential technological solutions for a project that looks to attain the close cycle of waste to energy and water generation through exploiting renewable technologies. EAWC has its corporate headquarters in Miami, Florida.

The Company notes that it is well positioned to offer engineering and technical consultancy. This is to design the most accurate renewable technology solutions to the above-mentioned problems and to leverage this fast-growing industry with manifold new markets.

EAWC has acquired the relevant licenses, which give the Company the right to sell and produce the associated technologies. This is while ensuring, via its partnership with Swiss Water Tech R&D, the provision of related services. These services include Research & Development, technical maintenance; education; as well as training.

Last month, EAWC announced it is launching The Blue Aqua Mission™ System. This is a state-of-the-art German engineered Atmosphere Water Generation (AWG) technology. It is totally powered by renewable energy.

This system consists of a set of intelligent software solutions for real-time optimization of process performance. It operates by way of its own unique self-powered system. The Blue Aqua Mission™ System concentrates on real-time automated optimization of the generation of water ensuring a stable operation with water generation up to 10,000 liters of water daily.

In addition, in March, EAWC announced that it plans to offer its Atmospheric Water Generation technological solutions via lease programs. The Company said that a number of interested parties, including South Africa, have expressed a desire to lease its technology offerings when made available. EAWC Technologies' commitment is to facilitate the access to water in several countries including South Africa through leasing The Blue Aqua Mission™ Systems.

Eurosport Active World Corp. (EAWD), closed Thursday's trading session at $0.9201, up 1.09%, on 400 volume with 1 trade. The average volume for the last 3 months is 2,885 and the stock's 52-week low/high is $0.10/$3.75.

chart

The QualityStocks Company Corner

Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF)

The QualityStocks Daily Newsletter would like to spotlight Canopy Rivers Inc. (RIV) (CNPOF).

Canopy Rivers Inc. (TSXV: RIV) (OTC: CNPOF) is pleased to announce that its portfolio company PharmHouse Inc. ("PharmHouse") has entered into a second offtake agreement (the "Agreement") with Canopy Growth Corporation ("Canopy Growth") (TSX: WEED) (NYSE: CGC) for the purchase of cannabis from its 1.3 million square foot greenhouse facility upon licensing. Also today, the company was featured on Investorideas.com's Investor Ideas Potcast http://ibn.fm/m4RYg .

Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) is the venture capital investment platform of Canopy Growth Corporation (TSX:WEED, NYSE:CGC).

Canopy Rivers is a unique investment and operating platform structured to pursue investment opportunities in the emerging global cannabis sector. Canopy Rivers collaborates with Canopy Growth to identify strategic counterparties seeking financial and/or operating support. Headquartered in Toronto, Canada, Canopy Rivers has developed an ecosystem of complementary cannabis operating companies operating throughout the cannabis value chain.

Canopy Rivers, in collaboration with Canopy Growth, has established a diverse portfolio of cannabis industry investments that includes domestic and international companies, licensed producers, late-stage licensed producer applicants, pharmaceutical formulators, brand developers and distributors, retail networks, and technology and media platforms. Investments are customized for each counterparty and include a balanced mix of equity, debt, royalty and profit-sharing agreements.

Canopy Rivers’ expanding portfolio includes:

  • Agripharm Corp. (private) is an ACMPR licensed producer, acquired by Canopy Growth in January 2017. In November 2017 Agripharm completed a joint venture with globally recognized partners Green House Seeds and Organa Brands. Canopy Growth has sublicensed proprietary technology, trademarks, genetics, know-how and other intellectual property from Agripharm to distribute the suite of Green House and Organa Brands products across the country, when permissible.
  • CanapaR Corp. (private) owns 80% of CanapaR Italy, a Sicily-based company focused on developing and commercializing Italy’s local hemp cultivation industry through its partnership with the renowned Department of Agriculture at the University of Catania and its rapidly building extraction capabilities for the production of organic CBD oil. CanapaR Italy’s outsource farming model with local Sicilian farmers and its university partnership will provide it with a low-cost source of organic CBD oil, which is increasingly used as an input into new commercial products in the growing health and wellness industries.
  • Civilized Worldwide Inc. (private), is a media and lifestyle brand with offices in New Brunswick and California that embraces and highlights modern cannabis culture. Civilized aims to engage the millions of productive, motivated people who choose to enjoy cannabis responsibly as part of their lifestyle. Reaching 2+ million unique visitors per month, North America-wide, Civilized produces engaging content for and about people who enjoy cannabis responsibly.
  • James E. Wagner Cultivation Ltd. (TSXV:JWCA) was founded in 2007 by third generation agricultural and cannabis cultivators. JWC is the first entirely aeroponic producer of cannabis in Canada, and its patent-pending aeroponic production technology, called GrowthStormTM, allows for perpetual harvesting and improved yields. The company was issued a license to cultivate from Health Canada in January 2017 and a subsequent sales license in March 2018.
  • LiveWell Foods Canada Inc. (TSXV:LVWL) was established in 1993 as a nutritional lifestyle company, and operates in the production of fresh produce and food technology. The company’s O-Hemp division distributes bulk and retail hemp products through its existing channel partners. LiveWell entered into a strategic agreement with Canopy Rivers and Canopy Growth in April 2018.
  • PharmHouse (private) is a joint venture between Canopy Rivers and the principals and operators of leading North American greenhouse produce companies. PharmHouse has arranged to acquire a newly built 1.3-million-square-foot greenhouse located in Leamington, Ontario.
  • Radicle Cannabis Inc. (private) is an ACMPR-licensed cannabis company based in Hamilton, Ontario backed by a management team that brings extensive experience in regulated industries, retail distribution, tobacco and pharmaceutical development, as well as Award-winning cannabis horticulturist breeders and medical professionals.
  • Solo Growth (TSXV:ALZ) is a new cannabis retail concept that will operate locations under the name “YSS by Solo,” relying on the expertise of a management team comprised of founding shareholders, senior officers and board members of Solo Liquor Stores Ltd., a leading Canadian liquor retailer. Solo Growth was established through a recapitalization of Aldershot Resources Ltd.’s corporate structure that will allow the company to execute a new retail-focused cannabis business strategy.
  • Spot Therapeutics Inc. (private) is an applicant that was acquired by Canopy Growth in August 2017 to solidify its Maritimes expansion strategy and less than four weeks later Canopy Growth signed a supply MOU with the New Brunswick government. Canopy Rivers purchased the property and entered into a long-term lease and committed funding agreement with Canopy Growth.
  • TerrAscend Corp. (CSE:TER) cultivates high-quality cannabis in an indoor hydroponic facility, backed by a strategic investor boasting a strong background in the pharmaceutical space and an extensive portfolio of specialty pharma assets.
  • Vert Mirabel (private) is a joint venture that was established in December 2017 between Canopy Rivers, Canopy Growth, and Les Serres Stephane Bertrand. Bertrand is a large-scale greenhouse operator located in Mirabel, Quebec, and the largest grower of pink tomatoes in the country. With guidance and assistance from Canopy Growth, the greenhouse has been upgraded and retrofitted for cannabis production and was licensed by Health Canada in May 2018.

As the company’s portfolio continues to develop, each constituent benefits from opportunities to collaborate with Canopy Growth and among themselves. Canopy Rivers believes this formula results in an ideal environment for innovation, synergy and value creation for Canopy Rivers, Canopy Growth and across the entire Rivers ecosystem.

Canopy Rivers is led by an experienced team of qualified financial and technical professionals with deep industry experience and relationship networks. The company’s acting CEO and chairman is Bruce Linton, CEO of Canopy Growth and founder of Tweed Marijuana.

Canopy Rivers Inc. (TSX.V: RIV), closed the day's trading session at $3.95, up 5.33%, on 106,720 volume with 1,165 trades. The average volume for the last 3 months is 117,144 and the stock's 52-week low/high is $2.40/$11.82.

Recent News

chart

Genprex Inc. (NASDAQ: GNPX)

The QualityStocks Daily Newsletter would like to spotlight Genprex Inc. (NASDAQ: GNPX).

Globenewswire rebroadcast news of the new Genprex Inc. (NASDAQ:GNPX) NetworkNewsAudio publication titled, "New Gene Therapies Hold Out Promise for Patients" today. To hear the NetworkNewsWire Audio version, visit: http://nnw.fm/D55vd. To read the full editorial, visit: http://nnw.fm/nhjN4.

Genprex Inc. (NASDAQ: GNPX) is a clinical-stage gene therapy company developing potentially life-changing technologies for cancer patients based upon a unique proprietary technology platform, including Genprex’s initial product candidate, Oncoprex™ immunogene therapy for non-small cell lung cancer (NSCLC). Genprex’s platform technologies are designed to administer cancer-fighting genes by encapsulating them into nanoscale hollow spheres called nanovesicles, which are then administered intravenously and taken up by tumor cells where they express proteins that are missing or found in low quantities.

Research and Development

Genprex holds a portfolio of 30 issued and two pending patents covering its technologies and targeted molecular therapies. The company’s research and development program is focused on identifying and developing leading-edge gene therapies that can be used alone or in combination with other therapies for treatment of cancer.

Genprex’s initial product candidate is Oncoprex™, an immunogene therapy for the treatment of non-small cell lung cancer (NSCLC). Oncoprex works by interrupting cell signaling pathways that cause replication and proliferation of cancer cells, re-establishes pathways for apoptosis (or programmed cell death) in cancer cells, and modulates the immune response against cancer cells. Oncoprex has also been shown to block mechanisms that create drug resistance.

Preclinical research is being conducted with the goal of developing Oncoprex to be administered with targeted therapies in other solid tumors, and with immunotherapies in NSCLC and other solid tumors. In addition, Genprex has conducted and plans to continue research into other tumor suppressor genes associated with chromosome 3p21.3, as well as other potential applications of the company’s immunogene therapy platform.

Clinical Trials

Genprex is currently conducting the second phase of a phase I/II clinical trial at the University of Texas MD Anderson Cancer Center in Houston. The company plans to expand its clinical program by adding a new clinical study evaluating Oncoprex™ in combination with a checkpoint inhibitor for treatment of Stage IV or recurrent NSCLC. In research presented at the 2017 Annual Meeting of the American Association of Cancer Research in Washington, D.C., Genprex’s collaborators showed that TUSC2 in combination with PD-1 checkpoint inhibition has a significantly greater anti-tumor effect in lung cancer than either agent alone. The research also shows that TUSC2 in combination with PD-1 blockade has synergistic activity in upregulating natural killer (NK) cells, correlating with prolonged survival in mice.

TUSC2 (Tumor Suppressor Candidate 2) is a tumor suppressor gene that is absent or deficient in cancer cells of many different cancer types.

The Market

Genprex technologies seek to bridge a critical gap by combining with targeted therapies and immunotherapies to provide treatments to large patient populations who would otherwise not be candidates for those therapies or who have become resistant to them. Genprex technologies are being developed to overcome genomic limitations which are inherent in targeted therapies and immunotherapies in order to provide new treatment solutions to large cancer populations, such as those with lung cancer.

Each year, more people die of lung cancer than of colon, breast and prostate cancers combined. NSCLC is the most common type of lung cancer, accounting for about 85 percent of all lung cancers, according to the American Cancer Society (“ACS”). Despite radical advances in drug development and novel therapeutic standards, survival for late stage lung cancer has not improved significantly in the past 25 years.

Senior Management

Chairman and Chief Executive Officer J. Rodney Varner, JD, is a co-founder of Genprex and has served in these roles since August 2012. He has more than 35 years of legal experience with large and small law firms and as outside general counsel of a Nasdaq-listed company. Varner has served as counsel in company formation, mergers and acquisitions, capital raising, other business transactions, protection of trade secrets and other intellectual property, real estate, and business litigation. He is a member of the State Bar of Texas and has been admitted to practice before the U.S. Court of Appeals for the Fifth Court and the U.S. Tax Court.

Julien L. Pham, M.D., MPH, is president and chief operating officer of Genprex. In March 2013, Dr. Pham co-founded RubiconMD, a healthcare IT company that connects primary care providers to specialists for additional guidance and opinions on medical cases and served as its chief medical officer. He has served on the faculty at Harvard Medical School’s Brigham and Women’s Hospital and is a board-certified internal medicine doctor and nephrologist.

Ryan M. Confer, MS, has served as Genprex chief financial officer since September 2016. Confer has more than 10 years of executive experience in planning, launching, developing, and growing emerging technology companies and has served in the chief operating and chief financial roles for non-profit and for-profit entities since 2008. Confer has also served as an international business development consultant for the University of Texas at Austin’s IC2 Institute, where he focused on evaluating the commercialization potential of nascent technologies in domestic and international markets applicable to technology incubator programs associated with the University. Confer holds a BS in finance and legal studies from Bloomsburg University of Pennsylvania and an MS in technology commercialization from the McCombs School of Business at the University of Texas at Austin.

Jan Stevens, RN, is vice president of Clinical Operations. Stevens has nearly 20 years of comprehensive clinical operations experience in the biopharma industry and a specialization in early-to-late stage oncology companies. Stevens joined the company to help support the various clinical development programs for Oncoprex™.

Genprex Inc. (NASDAQ: GNPX), closed the day's trading session at $1.85, up 0.54%, on 46,560 volume with 207 trades. The average volume for the last 3 months is 48,385 and the stock's 52-week low/high is $0.95/$15.0871.

Recent News

chart

Chemistree Technology Inc. (CSE: CHM) (OTC: CHMJF)

The QualityStocks Daily Newsletter would like to spotlight Chemistree Technology Inc. (CSE: CHM) (OTC: CHMJF).

Extolling the benefits of cannabidiol (CBD), A-List celebrities are hosting parties like baby showers that included CBD and meditation. This is just the latest in celebrity endorsements for new CBD products coming from a variety of companies including Chemistree Technology Inc. (CSE:CHM) (OTC:CHMJF). Also today, the company was featured in the 420 with CNW by CannabisNewsWire.

Chemistree Technology Inc. (CSE: CHM) (OTC: CHMJF), an investment company focused on the U.S. and international cannabis sectors, provides turnkey solutions for the regulated cannabis industry. The company leverages managements' expertise and decades of experience in the cannabis industry to acquire and develop vertically integrated cannabis assets. Chemistree recently closed on a purchase of prospective cannabis cultivation property in California, made a first investment in the Canadian cannabis industry, owns assets in the State of Washington used to operate an established retail cannabis brand, and has an active pipeline of assets in place to grow its portfolio.

Chemistree offers industry leading expertise across all areas the cannabis business and in its growth as a public or private company.

  • Investment and funding for rapid growth
  • Vertical integration solutions
  • Construction, design and/or optimization of indoor or outdoor cultivation facilities
  • Reputation management & influencer outreach
  • Branding and Packaging
  • Social Media and Media outreach

With the marketing of cannabis companies and their products in its infancy, the company believes the industry offers tremendous opportunity for growth in the U.S. and abroad. Chemistree initially targeted the Pacific Northwest for investment and, following its recent California property purchase, expects to expand vertically across the United States in areas where it has a competitive business advantage.

Through its wholly owned CHM Desert LLC subsidiary, Chemistree owns 9.55 acres of undeveloped land in Desert Hot Springs, California. The property is zoned as Light Industrial Lands Designated for Marijuana Cultivation, and local zoning ordinances allow as a conditional use the location of up to three onsite cannabis cultivation buildings of 68,000 square feet each, along with support space that would support production of 55,000 pounds/year.

Through its wholly owned Chemistree Washington Ltd. subsidiary, Chemistree acquired physical assets used in the cultivation, production and distribution of cannabis. The Washington assets are currently under lease to Sugarleaf Farm LLC, which operates the Sugarleaf brand of retail cannabis products in the State of Washington. Sugarleaf Farm is a Tier 3 cannabis producer and processor whose products are sold in about 125 retail outlets. Chemistree has indicated the relationship with Sugarleaf may provide the company with additional opportunities to become involved in the marketing of Sugarleaf products.

Chemistree funded these acquisitions and investments with the proceeds of two non-brokered private placement financings completed earlier this year under the regulations of the Canadian Securities Exchange, totaling CAD$4.5 million. In conjunction with the private placements, the company was granted approval by the CSE for a change of business to become an Investment Issuer. This funding is expected to provide the company "maximum flexibility to take advantage of the numerous opportunities available in the cannabis industry in Canada and the U.S."

Chemistree also has a strategic investment in Pasha Brands Ltd., a British Columbia based cannabis company with multiple internationally recognized brands. Pasha has a proven history in cannabis retailing and its proposed Licensed Processing (LP) facility on Vancouver Island is in the final stage of the application for government approval. The LP facility is expected to assist in licensing selected craft growers of cannabis and expanding the distribution of locally grown product. The investment represents less than 10% of Chemistree's working capital.

Company Chairman Justin Chorbajian is co-owner of the largest chain of privately owned hydroponic retail shops in Canada. He also cofounded a group of companies that manufacture and distribute hydroponic equipment. He is a frequent contributor to Growing Exposed, the leading video series dedicated to cannabis cultivation. Company President Karl Kottmeier is a former investment advisor with 20 years of experience listing, financing and administering companies on the Toronto Stock Exchange and TSX Venture Exchange. He has raised more than $150 million in equity capital for ventures. Chemistree CFO Doug Ford has been general manager of Dockside Capital Group Inc., a private merchant banking and venture capital firm serving emerging growth companies. Sheldon Aberman, the most recent member of the Board, has managed, designed and created industry leading grow room designs around the world. Additionally, he has built several leading brands such as Frost Box and Black Label and is an expert in the accessory market (vape pens, silicon mats and extraction tools etc.).

Data firm Statista has forecast the U.S. legal cannabis market will be worth more than $24 billion by 2025. New Frontier Data, which focuses exclusively on the cannabis industry, projects the value of the Canadian domestic cannabis market that same year at CAD$9.2 billion.

Chemistree Technology Inc. (CHMJF), closed the day's trading session at $0.478, up 1.42%, on 152,394 volume with 127 trades. The average volume for the last 3 months is 79,277 and the stock's 52-week low/high is $0.268/$0.61.

Recent News

chart

ChineseInvestors.com (CIIX)

The QualityStocks Daily Newsletter would like to spotlight ChineseInvestors.com (CIIX).

ChineseInvestors.com, Inc. (OTCQB: CIIX) was featured today in the 420 with CNW by CannabisNewsWire. The government in New Zealand has released details of how a referendum will be conducted in 2020 on the legalization of recreational marijuana. The plan was released by Andrew Little, the Justice Minister, in a press release.

Founded in 1999, ChineseInvestors.com (CIIX) has become a leading financial information website for Chinese-speaking investors in the United States and China. Recognizing unprecedented opportunities in the U.S. cannabis industry, CIIX is also laying the groundwork to capitalize on growing demand for cannabidiol (CBD)-based nutrition and health products.

Through its primary website, www.ChineseInvestors.com, CIIX offers a variety of investor education products and services, including real-time market commentary, analysis and educational related services in Chinese language character sets; consultative services to smaller private companies considering becoming a public company; and advertising and public relations related support services.

At the center of this initiative is the ChineseInvestors Method, a unique integration of a disciplined investing process, web-based tools, personalized instructions and support. Using this strategy, CIIX provides reliable market information to help investors make informed investment decisions and meet their individualized financial goals.

CIIX is also leveraging its financial expertise to enter into the burgeoning CBD industry, which within a few years has grown from a relatively invisible sector to a billowing market expected to reach $2.1 billion in consumer sales by 2020.

The increasing demand for CBD-based products is a catalyst for innovative business endeavors. To this accord, CIIX has established a three-year development plan to capitalize on the convergence of CBD and the nutrition and health products market in mainland China, where the benefits of CBD oil have not been widely recognized.

Under a wholesale agreement with a reputable CBD health brand, CIIX is launching the world’s first online CBD health products store published in the Chinese language. The site, www.ChineseCBDoil.com, caters to a growing number of Chinese people awakening to the numerous health benefits of CBD oil for treatment of a variety of conditions such as anxiety, stress, poor sleep, Alzheimer’s disease, and more. CIIX expects to launch this website at the end of January 2017, and plans to sell CBD-infused products via online and in-store.

In conjunction, CIIX’s cannabis-focused “Yelp”-style mobile app is in development as a platform for Chinese people to review and discuss various cannabis products. The app will be the first marijuana social media mobile app designed for Chinese-speaking customers worldwide.

ChineseInvestors.com (CIIX), closed the day's trading session at $0.47, up 1.08%, on 21,888 volume with 16 trades. The average volume for the last 3 months is 67,501 and the stock's 52-week low/high is $0.365/$1.25.

Recent News

chart

Marijuana Company of America Inc. (MCOA)

The QualityStocks Daily Newsletter would like to spotlight Marijuana Company of America Inc. (MCOA).

Marijuana Company of America Inc. (OTCQB: MCOA), an industrial hemp company involved in the cultivation and distribution of hemp-derived products, recently announced the appointment of Edward Manolos as an independent director. NOTE TO INVESTORS: The latest news and updates relating to MCOA are available in the company's newsroom at http://nnw.fm/MCOA.

Marijuana Company of America Inc. (OTC: MCOA) (the "Company") are pioneers in the cannabis industry going back to 2009 when Don Steinberg, MCOA’s CEO, founded the first marijuana company ever to trade on a U.S. stock market, Medical Marijuana Inc. Since then, Don and his partner, Charlie Larsen, have formed Global Hemp Group and Marijuana Company of America. They have experienced the shift of legislation first hand, not only for the legalization of marijuana but also the emerging hemp-based CBD products.

The CBD market is growing exponentially and consequently the founders of MCOA have constructed their business model around the development of industrial hemp-based CBD products. The industrial hemp plant can be used to produce products that are carbon neutral or even carbon negative. It is one of the longest, strongest natural fibers on earth, used as a building material that is free of mold, pesticide-resistant, and fire proof. Hemp has also been described as a “super food,” which provides additional business opportunities. No part of the plant is left unused and the Company’s overall strategy is to take advantage of every profit center from farm to the multiple valuable finished products.

The cannabis and hemp industries are experiencing unprecedented growth that is expected to continue for many years as these industries are now accepted globally and continue to mature and expand. North American consumers spent $6.7 billion on legal cannabis products in 2016, up 34% from 2015’s $5 billion. This trend is widely expected to explode at a 27% compounded annual growth rate to reach $22.6 billion by 2021, according to ArcView Market Research.

The company offers investors the opportunity to be on the forefront of cannabis and hemp innovation through cultivation, processing in the legal cannabis and industrial hemp sectors. The Company’s business model includes producing a diverse portfolio of synergistic business segments that provide value to its shareholders. Its vertically integrated business model and distribution platforms are positioned to capture market share by developing recognizable and valuable brands.

Under the MCOA umbrella, wholly owned subsidiary hempSMART™, Inc. is committed to bringing high quality CBD-based products to the market through its affiliate marketing program. Through hempSMART, MCOA’s strategic approach to the distribution of products is through a networking architecture geared to maintain customer loyalty and capture market share. The patent-pending product “hempSMART Brain,” is designed to revolutionize the safe and effective support of healthy brain function. The brand new product, HempSMART DROPS, is a full-spectrum CBD tincture formulated with hemp and fractionated coconut oils. The hempSMART marketing team has decades of experience, and is well positioned to take the hempSMART brand to a global audience.

Marijuana Company of America Inc. (MCOA), closed the day's trading session at $0.0148, up 6.47%, on 17,086,646 volume with 573 trades. The average volume for the last 3 months is 11,672,059 and the stock's 52-week low/high is $0.01025/$0.0498.

Recent News

chart

Sharing Services Global Corporation (SHRG)

The QualityStocks Daily Newsletter would like to spotlight Sharing Services Global Corporation (SHRG).

Sharing Services Global Corporation (OTCQB: SHRG) has introduced a new marketing program for the Hispanic community, which calls for the company to create Spanish versions of key marketing materials and websites. The goal of the program (http://nnw.fm/rR75V) is to broaden the customer and distributor base for SHRG's Elepreneurs subsidiary.

Sharing Services Global Corporation (SHRG), headquartered in Plano, Texas, is a diversified holdings company focused on reshaping how entrepreneurs succeed today. Sharing Services Inc. owns, operates or controls an interest in a variety of companies specializing in the direct selling industry that either sell products to the consumer directly through independent representatives or offer services that range from health and wellness, energy, technology, insurance services, training, media and travel benefits. SHRG has created the “Blue Ocean Strategy,” which melds three keys together to implement the company’s vision. These keys include elevating home-based entrepreneurs, known as “Elepreneurs,” utilizing the direct selling channel to generate 100 percent organic growth.

Sharing Services Inc. subsidiaries include:

  • A growing international network of home-based entrepreneurs, called “Elepreneurs”
  • Growing selection of health and wellness products dedicated to elevating the well-being of all people
  • Insurance from auto, home and life to health benefit discounts and health insurance that help families elevate their options
  • Wholesale travel and payment programs with travel concierges that empower more families to go on vacation
  • Live seminars and training events – from Vacationars™ to EduTainment – that elevate the skills and knowledge of entrepreneurs around the world
  • Unique compensation and reward programs crafted to help entrepreneurs elevate their health, wealth and happiness

Sharing Services recently expanded its corporate footprint by moving to a 10,000 square foot facility in Plano, Texas, that offers room to expand as the company grows and its subsidiaries flourish. The larger corporate locale provides space for a growing customer service department, product fulfillment, opportunity and training rooms, as well as a video production suite.

“The opportunity to expand to the rest of this new building over the course of the next six to 12 months ensures we won’t have to move again anytime soon,” Sharing Services Inc. Chairman Robert Oblon said. “We are on track for very significant growth here in the U.S., as well as upcoming international expansion, so this move is in preparation for what’s in front of us.”

The company recently signed a joint venture agreement with Health Wealth & Happiness Limited (“HWH”) to expand its “Elepreneurs” brand and market its products throughout Asia. The newly formed company will be named “Elepreneurs Asia Limited” and will have marketing and sales rights to China, Hong Kong, Macau, South Korea, Japan, Taiwan, Cambodia, Indonesia, Laos, Malaysia, the Philippines, Singapore, Thailand, Vietnam and Papua, New Guinea. A soft launch of the Elepreneur program is scheduled sometime later in 2018 with HWH CEP Fai Chan and his team leading the effort. Formed in Hong Kong, Health Wealth & Happiness Limited is dedicated to working with visionary partners like Sharing Services Inc. to deliver the best products and services to improve the well-being of consumers.

Nearly 1,000 people attended Sharing Services Global Corporation ’s first “Elepreneur Happiness Convention,” held March 2-3, 2018, in Dallas, Texas. Attendees arrived from several countries including the U.S., Canada, Mexico, Singapore and Hong Kong. Keynote speakers included several internationally known motivational leaders – Shawn Achor, Sandra Yancey, John Fleming and Les Brown – who provided exceptional material and inspirational discussion points.

“The enthusiasm of our attendees and the early success that we are experiencing is incredible considering our growth has been 100 percent organic, with almost no marketing from the company,” Oblon said. “I’m speechless by the dedication of our Elepreneur leaders and their entire teams, as they share our incredible line of products that have helped so many people.”

Sharing Services and its management team plan to travel the U.S. to hold several mini conferences to expand on the messages presented at its Happiness Convention that focus on helping people become “healthier, happier and wealthier.” Details of the company’s aggressive global expansion initiatives are soon to be announced, Oblon said.

The law firm of Gardere Wynne Sewell LLP has been retained as outside corporate counsel for all general business matters. The Dallas-based law firm will represent Sharing Services Global Corporation , and its subsidiaries as the company utilizes the direct selling channel for a significant component of its overall growth strategy.

John “JT” Thatchwas appointed president and chief executive officer of Sharing Services Global Corporation , at a March 1, 2018, annual shareholder meeting. Thatch has successfully started, owned and operated several sized businesses in various industries. His experience with corporate growth, acquisitions, financing and negotiation in fast-paced and flexible environments will significantly assist Sharing Services Inc. as the company aims to expand and increase revenues.

Sharing Services Global Corporation (SHRG), closed the day's trading session at $0.20, even for the day, on 5,000 volume with 4 trades. The average volume for the last 3 months is 31,746 and the stock's 52-week low/high is $0.17/$0.3944.

Recent News

chart

Black Iron Inc. (TSX: BKI) (OTC: BKIRF) (GR: BIN)

The QualityStocks Daily Newsletter would like to spotlight Black Iron Inc. (TSX: BKI) (OTC: BKIRF) (GR: BIN).

Black Iron Inc. (TSX: BKI; OTC: BKIRF; FRANKFURT: BIN) has renewed its Letter of Intent ("LOI") with Ukraine's National Railway to provide up to 10 Mtpa of capacity to move product from the railway line located within two kilometers of Black Iron's Shymanivske Project ("the Project") to Port Yuzhny, a deep water port in the Black Sea.

Black Iron Inc. (TSX: BKI) (OTC: BKIRF) (GR: BIN) is a Canadian iron ore exploration and development company advancing to production its wholly owned Shymanivske Iron Ore Project, located in Krivyi Rih, Ukraine. Black Iron’s Shymanivske project is situated in the southern part of the historic KrivBass iron ore mining district, a highly developed iron ore mining region with well-established infrastructure and nearby skilled labor forces. Surrounded by seven producing iron ore mines, the Shymanivske project will produce an ultra-high-grade, 68-percent iron ore concentrate with few impurities at very low cost.

The Market

Iron ore concentrates are one of the essential raw materials used by the steel industry to either make sinter or highly valued pellets. Black Iron’s concentrate can be used in either application and is an ideal source to make pellets since it does not need to be ground finer and contains very few impurities. According to the CRU Group, an internationally recognized top global business intelligence provider and consultancy specializing in commodities, there is a growing global shortage of pellet feed resulting in a supply/demand gap of 133Mt against the current base of approximately 400Mt consumed by 2035. According to a recent report issued by Zion Market Research, the global iron ore pellets market was valued at around US$25.22 billion in 2017 and is expected to reach US$50.12 billion by 2024, growing at a compound annual growth rate (CAGR) of 8.1 percent between 2018 and 2024 (http://nnw.fm/2vaDR).

Countries around the world, most notably China (http://nnw.fm/Je8gs), have instituted regulatory changes to curb polluting emissions from steel mills through numerous methods, including encouraging a shift to higher grade iron feed products such as pellets as less coal needs to be burnt per ton of steel produced.

Shymanivske Project

Black Iron’s Shymanivske’s project, which is expected to produce ultra-high-grade 68 percent iron content pellet feed iron concentrate, is generating significant interest from steel mills and global commodity trading houses. Use of ultra-high-grade 68-percent iron content product in the production of steel is a value-added product to customers since it increases blast furnace productivity and reduces greenhouse gas emissions generated per ton of steel produced.

The project’s proximity to rail lines (1 mile), electrical power (20 miles), sea ports (140 to 260 miles) and a skilled workforce (6 miles) significantly reduces the up-front construction costs and allows for the mine to be built in a phased approach. The Shymanivske project has been ranked by the CRU Group in the lowest position of the business cost curve for pellet feed projects currently under development and as the second lowest in capital intensity (construction capital divided by annual production) within CRU Group’s extensive database (http://nnw.fm/3MXsT). This low-cost position makes the project economics very robust to any shocks in iron ore price while providing a very high return at current and forecast prices.

Black Iron continues to advance its project on several fronts including construction funding and off-take agreements (http://nnw.fm/tQ4g2). Discussions with Ukraine’s Ministry of Defense to transfer a parcel of land required by the company for location of its processing plant, waste rock and tailings are nearing finalization, as are discussions with the Kryviy Rih City Council to lease a portion of the surface rights currently under that body’s control. The recent engagement of Ivan Markovich as Black Iron’s Vice President of Government and Community Relations will assist the company in these endeavors given his extensive network of relationships with senior Ukraine government officials.

The Shymanivske project holds a mining allotment permit for a large iron ore deposit with a NI 43-101 compliant resource estimated to contain 646 Mt (million tons) Measured and Indicated mineral resources, consisting of 355 Mt Measured mineral resources grading 31.6% total iron and 18.8% magnetic iron, and Indicated mineral resources of 290 Mt grading 31.1% total iron and 17.9% magnetic iron, using a cut-off grade of 10% magnetic iron. Additionally, there are 188 Mt of Inferred mineral resources grading 30.1% total iron and 18.4% magnetic iron.

Full mineral resource details and project economics can be found in the NI 43-101 compliant technical report entitled “Preliminary Economic Assessment of the Re-scoped Shymanivske Iron Ore Deposit” effective November 21, 2017, under the Company’s profile on SEDAR at?www.sedar.com.

Management

Black Iron’s management and board of directors is stacked with experts well-versed in successfully building and operating iron ore projects. CEO Matt Simpson, P.Eng. is the former general manager of Mining for Rio Tinto’s Iron Core Company of Canada and worked for Hatch designing global metallurgical refineries. He is also a Qualified Person as defined by NI 43-101. Chairman Bruce Humphrey is the former COO of GoldCorp and former chairman of Consolidated Thompson Iron Ore mines which was sold to Cliff’s resources for US$4.9 billion.

Les Kwasik, COO, has over 40 years of hands-on experience building and operating mines globally with companies such as INCO (VALE) and Xstrata (Glencore). Paul Bozoki, CFO, is the former CFO of CD Capital Partners, operating in the Ukraine. Bill Hart, senior vice president of corporate development, has over 30 years of experience selling iron ore while working for Rio Tinto, Cliffs Natural Resources and most recently Roy Hill Holdings Ltd. Ivan Markovich was recently engaged in the capacity of Black Iron’s vice president of Government and Community Relations to leverage his extensive network of relationships with senior Ukraine government officials.

Black Iron Inc. (BKIRF), closed the day's trading session at $0.06, even for the day, on 14,000 volume. The average volume for the last 3 months is 53,006 and the stock's 52-week low/high is $0.0285/$0.094.

Recent News

chart

Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF)

The QualityStocks Daily Newsletter would like to spotlight Green Growth Brands Inc. (OTCQB: GGBXF).

Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) was highlighted today in a publication from Financialnewsmedia.com, examining how global spending in the retail cannabis market is expected to grow 38% in 2019 to $16.9 billion, according to analysts at Arcview Group, growing to $31.3 billion by 2022.

Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) is a lifestyle-oriented cannabis and cannabidiol (“CBD”) consumer products company with a portfolio of lifestyle brands customized to connect specific, like-minded customers. Each Green Growth Brand provides the best quality products within a retail experience that appeals to users in an environment that is emotionally branded and easy to navigate.

In the next five years, the cannabis industry will generate more than $28 billion of new revenue from an estimated 14 million new customers, according to Ackrell Capital’s 2018 Cannabis Investment Report. Meanwhile, Hemp Business Journal projects that the CBD market will increase 8x to $3 billion by 2021, up from $200 million in 2017. Green Growth Brand intends to dominate in these markets with a lineup up products grown, manufactured and presented with the highest quality standards in mind.

Products under the Green Growth Brand umbrella include:

  • CAMP: A kiosk-type store where consumers can experience beautifully crafted lifestyle products that enhance one’s journey to self-discovery.
  • Seventh Sense: A CBD-infused body care collection crafted from the finest botanicals and fragrances on earth. Created to maximize the properties and aromatics of each ingredient, Seventh Sense natural products are CBD-infused botanical therapy.
  • Meri+Jayne: Fiercely authentic and wholly unapologetic, Meri+Jayne is a youthful, full-on celebration of what makes each person unique. Expect the unexpected when it comes to this mix of amazing products.
  • Green Lily: A place for women to explore a new world of wellness. With advice on every product, from efficacy to usage, Green Lily guides guests through beautiful new ways to experience cannabis and CBD.
  • The +Source: Located in Las Vegas and Henderson, Nevada, The+Source dispensaries operated by Green Growth Brands serve both medical patients and retail customers. Green Growth Brands also operates a grow and production facility in Post, Nevada, and recently entered into definitive agreements to acquire a Pahrump, Nevada, cultivation facility.
  • XanthicBiopharms is the owner of valuable intellectual property that turns THC(Tetrahydrocannabinol) and CBD into a water-soluble substance. As a result of combining Green Growth Brands and Xanthic, this technology is being used to create incredible new products.

Business Strategy

Green Growth Brands has identified numeroushitches in the current cannabis retail space. The company intends to counter these challenges and provide a customer experience ripe with a friendly staff, in-stock assortments, efficient operations and more. The company’s retail partners provide distribution opportunities within 4,000 stores, as well as robust and established digital platforms to best reach the modern consumer.

Management

Green Growth Brands brings together a collection of expert retailers, scientists, botanists, developers, artists and business leaders for the benefit of building community. Led by an executive management team steeped in decades of experience with several of America’s most successful brands, including Victoria’s Secret, American Eagle Outfitters, Bath & Body Works, Limited Brands and Designer Shoe Warehouse, Green Growth Brands is uniquely positioned to create memorable brands, retail experiences, and quality products for the emerging cannabis industry.

Chief Executive Officer Peter Horvath heads strategy and execution across all company channels, and previously took shoe retailer DSW public on the NYSE at $1.5 billion. As a dynamic, creative brand leader, team builder, and specialty retail veteran with deep roots in finance, Horvath’s unique ability to understand the big picture while never missing the subtle details is a critical factor in Green Growth Brands’ success and brand popularity among customers.

Chief Marketing Officer Scott Razek is a brand strategist, storyteller and strategic marketer. Razek‘s 25 years of experience in brand building, product development and customer experience focus are a key differentiator for the Green Growth Brands portfolio.

CAO Ed Kistner brings 33 years of multifaceted experience at leading retail businesses, notably in finance, merchandise planning, operations and stores. His well-rounded experiences in fast-changing environments position Kistner to be the architect of the operational execution at Green Growth Brands.

CSO Kellie Wurtzman brings significant retail leadership to Green Growth Brands with a proven track record of leading high-performance stores and teams across multiple retail sectors. Her unmatched experience in identifying and supporting developing business opportunities is ideal for evolving the cannabis industry and will be instrumental in expanding operations at Green Growth Brands.

Headquartered in Columbus, Ohio, Green Growth Brands is traded on the Canadian Securities Exchange and on the OTCQB, providing investors with increased access to data, transparency and liquidity.

Green Growth Brands Inc. (OTCQB: GGBXF), closed the day's trading session at $3.7385, off by 3.67%, on 242,915 volume with 608 trades. The average volume for the last 3 months is 248,134 and the stock's 52-week low/high is $1.8068/$5.205.

Recent News

chart

Kontrol Energy Corp. (CSE: KNR) (OTC: KNRLF) (FSE: 1K8)

The QualityStocks Daily Newsletter would like to spotlight Kontrol Energy Corp. (CSE: KNR).

Green digital technology platform developer Kontrol Energy Corp. (CSE: KNR) (OTCQB: KNRLF) (FSE: 1K8) has developed its model for energy efficiency promotion into a growing, thriving operation that reported strong year-over-year growth during the past year and record revenues during the fourth quarter.

Kontrol Energy Corp. (CSE: KNR) (OTC: KNRLF) (FSE: 1K8) specializes in the integration of smart energy technologies and solutions for North American commercial and industrial property owners and operators to help them benefit from energy cost savings and minimize greenhouse gas emissions. Kontrol is a leader in the energy efficiency sector through IoT, Cloud and SaaS technology and is ranked by Canadian Business and Maclean’s as the 7th fastest growing startup in 2018.

Kontrol’s leadership position is reshaping the way customers use, manage and strategically allocate energy resources to realize immediate energy savings by gaining more control over energy consumption and demand in real-time.

As the fastest growing global “fuel source,” energy efficiency is big business with industry analysts noting this multi-trillion-dollar market offers significant opportunities over the next five years. Established market segments include: energy retrofits ($71.4 billion); distributed generation ($179.9 billion); energy analytics ($33.5 billion); and greenhouse gas/carbon measurement, reduction ($1.2 trillion). Each $1 invested in energy efficiency displaces up to $3 of utility-scale transmission and distribution investment, according to the International Energy Agency.

Formed in 2015 by a group of energy veterans who recognized that the energy efficiency industry is one of the fastest growing fuel sources for the global economy, Kontrol is committed to enhancing and improving its customers sustainability objectives. In less than two years, Kontrol has grown its revenue run rate to $16 million from $1.8 million, delivering on stated goals and objectives as it seeks to continue this pattern through accretive acquisitions and the expansion of the company’s smart energy technologies.

Up to 50 percent of Kontrol’s overall revenues are recurring annually, and the company’s 2019 outlook includes strategic initiatives that will expand the company’s smart energy technologies to U.S. markets, bring additional accretive and strategic acquisitions, and accelerate recurring SaaS revenues.

Kontrol’s strategy of disciplined mergers and acquisitions includes the following highlights:

  • Acquisition of Log-One Ltd.’s award-winning energy conservation technology, Energy Management System (“EMS”), an intelligent, occupancy-based heating and air-conditioning control system for commercial and multi-residential real estate. Rebranded as Kontrol EMS Technology, the company has added IoT and mobile application capabilities, creating a recurring revenue platform through a Software-as-a-Service (SaaS) platform.
  • Acquisition of ORTECH Consulting Inc., an engineering consulting firm specializing in Greenhouse Gas (GHG) reporting, emission testing, air quality testing and renewable energy/power consulting.
  • Acquisition of Efficiency Engineering Inc. (“EE Inc.”), which provides engineering services to industrial, municipal and commercial building owners across Canada. EE Inc. provides detailed energy efficiency analysis, energy audits, management of facility system solutions, electrical and mechanical design and energy conservation studies.
  • Acquisition of MCW Dimax Ltd. (“MCX”), a firm specializing in solutions for the application of energy software to analyze the management of complex heating, ventilation and cooling systems for large residential, commercial, and mission critical real estate owners.
  • Acquisition of CEM Specialties Inc. (“CEMSI”), a market leader in turn-key emission monitoring, equipment and solutions.

The company has also established entry into the North American cannabis market as a supplier of integrated energy efficiency solutions and technologies. Within this market, Kontrol is focused on assisting cannabis growers to reduce the cost of energy and support mission critical infrastructures. To date, Kontrol has secured two contracts to provide energy efficiency services with Licensed Producers in the Canadian cannabis sector.

The Kontrol Energy group of companies is currently saving its customers more than 40 million kilowatt hours of electricity per annum and providing a corresponding reduction in GHG emissions.

Kontrol’s management team includes CEO Paul Ghezzi, a leader in clean tech, renewable energy development, solar project financing and distributed generation. Ghezzi has global experience in power generation projects under Feed-in Tariff programs and Power Purchase Agreement programs for both commercial and utility-scale projects. COO Kristian Lavereau has more than 25 years of experience in the IT solutions (analytics and mobile computing), energy optimization and efficiency (intelligent control systems, solar PV, lighting). Claudio Del Vasto, CPA, CA | CFO, is a senior finance executive with an extensive background in corporate finance, strategy and business development.

Kontrol Energy Corp. (CSE: KNR), closed the day's trading session at $0.73, off by 2.67%, on 242,915 volume with 8 trades. The average volume for the last 3 months is 248,134 and the stock's 52-week low/high is $0.46/$0.99.

Recent News

chart

Phivida Holdings Inc. (CSE: VIDA) (OTC: PHVAF)

The QualityStocks Daily Newsletter would like to spotlight Phivida Holdings Inc. (PHVAF).

Premium functional food and beverage company Phivida Holdings (CSE: VIDA) (OTCQX: PHVAF) this morning announced its plans to launch a range of hemp-derived CBD pet products. To view the full press release, visit: http://nnw.fm/UDXp5.

Headquartered in Vancouver, Canada, with operations in San Diego, Calif., Phivida Holdings Inc. (CSE: VIDA) (OTC: PHVAF)  is a premium food and beverage company that focuses on whole plant nutrition and natural ingredients that help best maintain overall health and balance in the human body. The company infuses active hemp into a variety of premium foods, beverages and supplements and is poised for global distribution. Phivida is guided by a team of Fortune 500-caliber executives focused on a new strategic portfolio of products and brands, comprehensive consumer research, new product and brand development, improved visual identity and packaging design, and a strong distribution strategy.

The company’s mission is to become a leader in whole plant solutions by providing holistic remedies for a more natural alternative to pharmaceuticals and by guiding people toward a healthy lifestyle. Phivida embraces and celebrates a return to organic, natural, plant-based foods and beverages and a focus on holistic health and wellness.

Publicly traded on the Canadian Securities Exchange (CSE: VIDA) and the OTCQX Best Market in the U.S. (OTC: PHVAF), the company’s strong balance sheet carries CAD$13 million with no debt or loans with ~60 million shares outstanding, and the company is now well-capitalized to fund major mainstream distribution with a solid structure that is poised for long-term growth.

Management

Phivida’s management team includes president and CEO Jim Bailey, former president of Red Bull Canada and global chief marketing officer for Merrell Outdoors; Chief Marketing Officer Michael Cornwell, former chief marketing officer for Samsung New Zealand and the former director of marketing for Red Bull Canada; and Doug Campbell, former director of sales for Red Bull North America, who, as Phivida’s chief commercial officer, is tasked with driving new sales revenue growth.

The Science

Using encapsulation technology, Phivida uses full spectrum CBD-hemp oil (rich in naturally occurring phytocannabinoids) converted into a water-soluble delivery format, which enhances delivery and absorption of the cannabinoids into the human body – up to an estimated tenfold.

The whole plant hemp extract is infused into functional beverages, food and supplements to target a range of health and wellness conditions. Phivida strives to lead the industry in product quality through high-quality ingredients and best-in-class testing. The Company has partnered with Flora Labs to test and ensure consistency and potency of all products. Flora Labs is a world-class testing lab with stringent QA and QC quality assessment protocols and will provide Phivida with ongoing impartial quality testing.

Regulations

Federally legal under the 2014 Farm Bill, CBD from hemp oil is a rapid growth market across the U.S. When derived from marijuana, CBD remains a schedule 1 controlled substance, giving hemp-derived CBD oil-infused products a competitive advantage on regulations. On June 28, 2018, the U.S. Senate passed the Agriculture Improvement Act of 2018 (i.e. the “Farm Bill), lifting the U.S. Industrial Hemp laws to an agricultural commodity status and effectively removing hemp from the controlled substance list.

Earlier this year, another milestone court ruling also provided significant regulatory support for the U.S. CBD-hemp sector. In February 2018, the Supreme Court presided over the HIA (Hemp Industry Association) vs. DEA (Drug Enforcement Agency) in a class-action suit concerning the issue of CBD extracted from hemp and the legality of industrial hemp. In the final ruling, the Supreme Court unequivocally determined that hemp (and its derivatives), when produced domestically under the Farm Bill, are not a controlled substance.

The Supreme Court ruling also found the Farm Bill (as it relates to hemp) “pre-empts” the Controlled Substances Act. Congress has since exempted Farm Bill hemp from the Controlled Substances Act (CSA), giving the Farm Bill primary jurisdiction over the governance of the CBD-hemp oil industry in the U.S.

The DEA further conceded it does not “seek to control cannabinoids” and that only marijuana-derived cannabinoids are governed under the Controlled Substances Act. In May of 2018, the DEA issued a formal directive to all federal agencies (e.g., U.S. Customs and Border Patrol) stating that cannabinoids are not controlled substances unless derived from marijuana, and that the “mere presence of cannabinoids” in any product or derivative does not render it a controlled substance. The Supreme Court ruling also resulted in the mediation of a settlement in what is now the third successful HIA vs. DEA suit in over a decade.

In Canada, the Senate approval of Bill C-45 legalized the production, distribution and use of recreational cannabis, with edibles to be added in 2019. The bill officially became law as of Oct. 17, 2018, creating a legal framework for the production, distribution, sale and possession of cannabis across Canada including cannabinoid-infused beverages.

Phivida Brands

  • Vida+: Vida+ is the company’s premium, clinical-grade-strength, full-spectrum hemp oil extract and capsule line designed to help people feel their best. The products are sourced from the best organic hemp and natural ingredients on the market and are third-party lab tested for quality, purity and potency at world-class facilities.
  • Oki: The Oki lifestyle brand is the company’s newly launched line of functional beverages and supplements infused with active hemp extract and will be available to consumers in up to 2,400 natural specialty store locations within the United States. Oki beverages are infused with 10 milligrams of active hemp extract per bottle and come in two different formulations: iced teas and flavor-infused water, each available in four different 16-ounce flavors. Oki supplements are available in tinctures or capsules that range in doses from 600-1,800 total milligrams of active hemp extract.
  • All products contain non-GMO, natural and organic ingredients and are plant-based and vegan friendly and packaged in sleek, 100 percent recyclable glass containers.

WeedMD-Phivida Joint Venture

Phivida has partnered with WeedMD Inc. (TSX-V: WMD) (OTC:WDDMF) (FSE:4WE), a Health Canada federally licensed producer and distributor of medical cannabis, to form a joint venture focused on manufacturing, marketing and distributing cannabinoid-infused beverages. CanBev is on track to build and operate the first cannabis-infused beverage production facilities in Canada. The joint venture will focus on manufacturing, marketing and distributing cannabinoid-infused beverages for the legalized medical and adult-use cannabis markets. WeedMD will be the exclusive cannabis supplier and distributor for CanBev cannabis-infused beverages. Phivida will be responsible for product innovation, research and development, formulation and branding.

Strategic Agreements

Phivida has an exclusive national agreement with Natural Specialty Sales (“NSS”), an Acosta company. NSS is recognized as the industry leader in natural/specialty retail channel trade across the U.S. Phivida’s launched OKI brand of premium CBD products is now the exclusive CBD-infused beverage and health supplements products brand represented by NSS. This establishes Phivida as the first CBD brand company to officially cross over into national mainstream distribution across the U.S., providing new access to over 2,400 retail locations in a major distribution channel market valued at over USD $4.1 billion in retail sales.

The NSS exclusive agreement provides access to a national network of retail stores across the U.S. This national network includes major retail banners such as: Whole Foods Market, Sprouts Farmers Market, National Coop Grocers, etc. The partnership also provides the opportunity to access an additional 25,000 national conventional grocery supermarkets, including Walmart, Target, Kroger, Publix and others, via Acosta’s national sales network.

Further Information

www.Phivida.com
+1 (844) 744-6646 (ext. #2)
IR@Phivida.com

Phivida Holdings Inc. (PHVAF), closed the day's trading session at $0.4994, off by 3.58%, on 87,724 volume with 44 trades. The average volume for the last 3 months is 130,900 and the stock's 52-week low/high is $0.344/$1.059.

Recent News

chart

TransCanna Holdings Inc. (CSE: TCAN)

The QualityStocks Daily Newsletter would like to spotlight TransCanna Holdings Inc. (CSE: TCAN).

Transcanna Holdings Inc. (CSE:TCAN: XETR: TH8) ("TransCanna" or the "Company") is pleased to announce the execution of a non-binding letter of intent with Persuasion Brewing Co. ("Persuasion" or "PBC"), a private brewing company located in Modesto, California. Both companies have agreed to create a division within TransCanna's recently purchased 196,000-square-foot vertically integrated facility (the "Facility") to establish a Persuasion Brewing division, which will produce a variety of different CBD infusion non-alcoholic beers. Also today, CannabisNewsWire released an editorial on the company. To view the full publication, titled "Full-Spectrum Seed-to-Sale Model, Quality Branding Key to Cannabis Success," please visit: http://cnw.fm/T8uWw. Additionally, the company was highlighted on BTV- Business Television, as BTV unveiled how TCAN's large California facility will become their own self-contained ecosystem to grow, manufacture and distribute cannabis. See Feature

TransCanna Holdings Inc. (CSE: TCAN) through its subsidiaries specializes in assisting clients who are cannabis farmers and manufacturers get recognized by end consumers who in turn purchase their products. TransCanna offers or will be offering services to support almost every aspect of the cannabis-related eco-system; from branding and design, to transportation and distribution, to marketing and sales.

California’s legalized adult-use recreational marijuana market opened for business January 1, 2018. The state’s Bureau of Cannabis Control is responsible for regulating all commercial activities in the state including cultivation, distribution and transportation. Moving cannabis products in the California marketplace is extremely challenging due to municipal and state laws and regulations, which can differ among cities and counties. Since cannabis remains illegal under federal law, Department of Transportation regulated companies are barred from participating in the market, which means companies looking to excel in the sector must hold a state-issued distributor license from the Bureau of Cannabis Control.

TransCanna has already entered into an Intellectual Property Rights and Royalty Agreement for the Track & Trace software platform required by the state of California. TCM Distribution, the operating company managed by TransCanna, has received a transportation and distribution permit from the city of Adelanto and a temporary transportation and distribution permit from the state of California. TransCanna has also executed a land lease to build a 10,000-square-foot transportation and distribution facility in Adelanto.

TransCanna is strategically creating a distribution network throughout California that places its facilities no further than a three-hour drive from most any client. The company is in the process of leasing or purchasing properly licensed and permitted warehouses strategically located throughout California along with new secure trucks, sprinter vans and/or armored vehicles.

TransCanna plans to create its own portfolio of branded products for the cannabis and hemp sectors. The company’s management team intends to translate the skills, knowledge and experience gained from a combined 60 years of branding and marketing experience in the music, professional sports and alcohol industries into TransCanna and the cannabis industry.

As part of the “TransCanna Way,” the company intends to manage most aspects of the supply chain from upper end procurement, branding, transportation and distribution, to marketing and sales.

Leading TransCanna as its CEO and chairman is James Pakulis, who has three decades of experience working with public and private entrepreneurial companies in a variety of emerging and high-growth sectors. He is formerly the president and a director of Lifestyle Delivery Systems Inc. (CSE: LDS) (OTCQB: LDSYF), a vertically integrated cannabis-related entity operating in California. Pakulis was chairman and CEO of General Cannabis Inc. which from 2010 to 2012 owned WeedMaps. Pakulis oversaw the company’s growth from zero to over $16 million in annual revenue in less than 24 months.

The company’s strategic advisors include individuals with extensive experience in branding, marketing, sales, distribution, production and supply chain management.

For additional information, call: (604) 609-6199

TransCanna Holdings Inc. (CSE: TCAN), closed the day's trading session at $6.59, up 2.81%, on 91,428 volume with 188 trades. The average volume for the last 3 months is 166,315 and the stock's 52-week low/high is $0.77/$7.79.

Recent News

chart

The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF)

The QualityStocks Daily Newsletter would like to spotlight The Green Organic Dutchman (OTC: TGODF).

The Green Organic Dutchman Holdings (TSX: TGOD) (OTCQX: TGODF), a cannabis-focused research and development company, this morning announced that it has obtained a cannabis supply agreement with the BC Liquor Distribution Branch ("BCLDB"), under the brand BC Cannabis Stores. To view the full press release, visit: http://nnw.fm/fGk5V. Also today, the company was highlighted in an article examining how nearly 7% of Americans use CBD, according to Cowen & Co. analysts.  In fact, according to Cowen's January 2019 consumer survey of 2,500 adults, 6.9% of respondents are using CBD.

The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF), whose principal location is in Hamilton, Ontario, produces farm grown, organic, pesticide-free medical cannabis in small batches using all natural, organic craft growing principles. TGOD is licensed under the Access to Cannabis for Medical Purposes Regulations (ACMPR) to cultivate medical cannabis. The company carries out its principal activities producing cannabis pursuant to the provisions of the ACMPR and the Controlled Drugs and Substances Act (Canada).

Committed to becoming the global leader in delivering organic cannabis solutions that enhance people’s lives, TGOD consistently adheres to the highest levels of excellence. Its world-class management team includes a proven group of leaders with outstanding executive and operational experience specific to consumer packaged goods, consumer products, cannabis and finance industries.

TGOD is positioned as one of the highest quality and most cost efficient cannabis producers in Canada by leveraging innovative technology and low-cost power solutions. It holds one of the largest land packages under a single ACMPR license in Canada, providing future cannabis Agri-park style development and opportunities for joint ventures, licensing and distribution partners. Its industry leading alliance partners include Eaton, Ledcor Group and Hamilton Utilities Corp.

Eaton is the second largest power management company in the world and promises to supply innovative and cost effective power solutions to meet TGOD’s growing demands. Construction management is supplied by Ledcor, Canada’s second largest multidisciplinary construction company and a pioneer in the Green Building Industry. An alliance with Hamilton Utilities Corp allows TGOD to reduce its power costs from $0.13 per kWh to less than $0.05 per kWh. Greenhouse design is provided by Larssen Greenhouse, whose 25-plus years of experience in building some of the most modern and sophisticated greenhouses in the industry will provide TGOD with state of the art, climate-controlled hybrid greenhouse solutions.

Canada is quickly becoming a hub for cannabis investors with over $1.3 billion raised by Canadian companies to date. There are 58 licensed producers to service a population of 36 million and only two organic producers. TGOD, which holds licenses in Ontario and Quebec, is strategically located in both provinces that together claim 22 million Canadians as residents. Another estimated 57 million people live next door in six U.S. bordering states.

The Canadian cannabis market currently has a massive supply demand gap, which makes TGOD’s expansion plans even more important to investors. These plans include a combined build-out capacity of 970,000 square feet, allowing TGOD to produce 116,000 kg annually of organic cannabis. Upon completion, Phase One in Hamilton, Ontario, which is fully funded, will provide 150,000 square feet of growing capacity capable of producing up to 14,000 kg of cannabis or $112 million in revenue at $8 a gram.

The company’s Quebec expansion will be constructed on a recently secured 75-acre property near Montreal. This new property has a planned expansion of 820,000 square feet capable of producing 102,000 kg of organic cannabis. The first phase of this expansion is underway and construction is expected to be completed by the end of 2018. Quebec’s first phase will consist of 220,000 square feet capable of producing 22,000 kg of cannabis. Two additional expansion phases will add 250,000 square feet (26,000 kg of cannabis) and 350,000 square feet (54,000 kg of cannabis). Power costs remain exceptionally low for both facilities with access to all other needed utilities available and close by.

TGOD also plans to gain a share of the burgeoning cannabis oils market which by Q1 2017 accounted for 49 percent of all cannabis sold in Canada under the ACMPR, up from only 27% in Q2 2016. TGOD has ordered a purpose-built extraction laboratory with an estimated commission in Q4 of 2017. This is a commercial-scale CO2 extraction unit capable of processing up to 12,000 kg of raw material per year and producing approximately $170 million worth of organic cannabis oils. Raw cannabis oil provides a significant downstream manufacturing opportunity into several potential recreational market verticals including edibles, beverages, topicals and concentrates.

Data from the Canadian ACMPR Market Trends report indicates a rising number of consumers will continue to seek out healthier, less conspicuous ways to consume cannabis, ensuring sales of organic cannabis oil products remain brisk. Organic cannabis products demand a significant premium compared to non-organic products and the demand keeps growing.

Plans to take the company public are underway with an initial public offering (IPO) slated for January 2018. In November, the company raised $13 million in equity financing and in March closed a $27 million non-brokered private placement. Another $20 million is currently being raised before the IPO in January, which will be utilized for expansion plans.

TGOD is uniquely positioned between the medical and recreational cannabis industry since Canada is scheduled to legalize cannabis for all adults in mid-2018. As of August 2017, TGOD has 2,400 shareholders. Established in 2012, TGOD’s motto, “Making Life Better,” can be seen in its strategic partnerships, top quality management team, and dedication to organic farming and principles.

To learn more about the company and how to invest, contact TGOD directly at financing@tgod.ca

The Green Organic Dutchman (OTC: TGODF), closed the day's trading session at $3.018, off by 4.86%, on 749,688 volume with 1,136 trades. The average volume for the last 3 months is 1,237,149 and the stock's 52-week low/high is $1.607/$7.894.

Recent News

chart

Earth Science Tech, Inc. (ETST)

The QualityStocks Daily Newsletter would like to spotlight Earth Science Tech, Inc. (ETST).

Florida-based biotech company Earth Science Tech Inc. (OTCQB: ETST) operates in the fields of hemp cannabinoids, nutraceuticals, pharmaceuticals, medical devices, and research and development. The company is passionate about the products that it offers and is dedicated to providing the highest-quality products and devices at affordable prices to meet a burgeoning global need.

Earth Science Tech, Inc. (ETST) is an innovative biotechnology company operating in the fields of hemp cannabinoid (CBD), nutraceutical, pharmaceutical and medical device research and development. Earth Science Tech offers the highest purity and quality, full-spectrum, high-grade hemp CBD (cannabidiol) oil on the market. Made using the supercritical CO2 liquid extraction process, the company’s CBD oil is 100 percent natural and organic. Earth Science Tech has partnered with the University of Central Oklahoma and DV Biologics Laboratory to conduct research and development projects that scientifically support and advance the healthcare benefits of its high-grade hemp CBD oil.

Earth Science Tech Inc. currently has three wholly owned subsidiaries focused on developing its role as a world leader in the CBD space and expanding its work in the pharmaceutical and medical device sectors. These subsidiaries include:

  • Earth Science Pharma, Inc., which is committed to development of low cost, noninvasive diagnostic tools, medical devices, testing processes and vaccines for sexually transmitted infections and/or diseases. Earth Science Pharmaceutical CEO and chief science officer Michel Aubé is leading the company’s research and development efforts. The company’s first medical device, MSN-2, is a home kit designed for the detection of STIs, such as chlamydia, from a self-obtained gynecological specimen. Earth Science Pharma is working to develop and bring to market medical devices and vaccines that meet the specific needs of women.
  • Cannabis Therapeutics, Inc. (“CTI”), which is poised to take a leadership role in the development of new, leading-edge, cannabinoid-based pharmaceutical and nutraceutical products. CTI is invested in research and development to explore and harness the medicinal power of cannabidiol. The company holds a provisional application patent for a CBD product that is focused on developing treatments for breast and ovarian cancers.
  • KannaBidioiD (“KBD”) provides a wide variety of products geared toward the recreational space of cannabis. KBD’s unique Kanna and CBD formulation is sold and distributed in CBD-infused edibles and vapes/e-liquids products. Kanna and CBD synergistically enhance one another, providing optimal relaxation, an uplifting sensation, enhanced focus and the added benefit of assisting with nicotine reduction therapy.

Earth Science Tech celebrated a significant, developmental year during 2017 by sharing its achievements in a condensed end-of-year report. Among the report’s highlights are the implementation of a development plan for the coming three years, which includes expanding into Canada and opening new manufacturing and shipping facilities. Of particular interest is the acquisition of Canna Inno Laboratories Inc., a company headquartered in Montreal, Quebec, Canada, which gives Earth Science Tech access to Canadian government grants offered to innovators in the pharmaceutical industry. ETST has also launched development of proprietary prophylactic therapies utilizing cannabidiol (CBD) to treat various forms of breast cancer.

In October 2017, ETST announced it is cooperating with the Clinique SIDA Amité (AIDS Friendship Clinic) for a mini-clinical trial, the last trial needed before the MSN-2 device, designed for the detection of STIs, enters molecular diagnostic trials. And in November 2017, the company began pre-launch human trials on a new CBD formula to fight against the U.S. opioid epidemic. The new formula, expected to decrease cravings and the negative effects of withdrawal in addicts, is based on industrial hemp CBD mixed with a known natural ingredient proven to help increase dopamine levels. ETST’s medical devices will first be launched in Vietnam, Djibouti and Morocco while the company awaits regulatory permission to enter the North American market.

The company expects to up-list to the OTCQB in early 2018, which management believes will attract well-funded institutional investors and pave the way to becoming the next billion-dollar-in-capitalization company on the OTC markets. Other highlights include completion of the company’s Scientific Advisory Council with a team of recognized scientists, the launching of several CBD-infused edible products and entry into the medical devices market through collaborative partnerships.

Earth Science Tech has signed a collaborate agreement with Laboratories BNK Canada, a private laboratory that will conduct the clinical studies necessary for MSN-2 medical device-related services to meet regulatory requirements. ETST has confirmed the MSN-2 device’s ability to detect chlamydia, and is working to validate similar results for gonorrhea, both highly infectious diseases that often have permanent consequences for patients. ETST will also add testing for trichomoniasis and a complete body fluid panel to detect the different serotypes of the human papillomavirus (HPV) that causes cervical cancer. These additions will help the company create sales opportunities in the global market for diagnostic testing of STDs that Transparency Market Research has indicated will grow to $108 billion by 2019.

Cannabis Therapeutics is in the development stage of two cannabinoid-based pharmaceutical drugs and three cannabinoid-based nutraceutical products targeting a variety of ailments such as anxiety, depression, triple negative breast cancer, and fatty liver disease, among others. Research into the benefits of the non-psychoactive cannabinoid molecules found in the cannabis plant is supported by ETST’s International Application for Provisional Patent titled “Cannabidiol Compositions Including Mixtures and Uses Thereof,” which was filed on October 8, 2015. Cannabis Thera’s R&D efforts are concentrated on developing CBD-based drugs and nutraceutical products and in working to integrate the CBD molecule with existing generic drug molecules to create more efficient medications with fewer and less severe side effects. A report in Hemp Business Journal predicts the CBD consumer market will grow to $2.1 billion by 2020, while other industry experts expect an increase to almost $3 billion by 2021. A recent report by Statista projects the U.S. consumer market for cannabinoid-based pharmaceuticals could reach $50 billion by the year 2029.

The management team at Earth Science Tech brings decades of invaluable experience to the nutraceutical, dietary supplement field as well as the life sciences sectors. Nickolas S. Tabraue, who serves as the president, director and chief operating officer, is an industry veteran with extensive knowledge of supplements, retail management, customer service and sales expertise. He is joined by CEO and CSO Dr. Michel Aubé, a microbiologist whose scientific research in sexually transmitted infections, cancer and stem cell biology has been widely published in several prestigious medical journals. Sergio Castillo, chief marketing officer, and Gabriel Aviles, chief sales officer, bring a wealth of marketing and sales experience to Earth Science Tech, which is complemented by Issa El-Cheikh, Ph.D., and his 25 years in the international finance, accounting, planning and execution of large scale transactions in the public and private sectors.

Earth Science Tech’s products include CBD, a natural constituent of hemp oil derived from hemp stalk and seed. EST offers CBD in the form of vitamins, minerals, herbs, botanicals, personal care products, homeopathies, functional foods and other products delivered in such forms as capsules, tablets, soft gels, chewables, liquids, creams, sprays, powders and whole herbs. Earth Science products can be found at retail stores throughout the United States and are available for purchase through the internet.

Earth Science Tech, Inc. (ETST), closed the day's trading session at $0.4999, off by 0.02%, on 670 volume with 5 trades. The average volume for the last 3 months is 35,047 and the stock's 52-week low/high is $0.375/$2.45.

Recent News

chart

VPR Brands, LP (VPRB)

The QualityStocks Daily Newsletter would like to spotlight VPR Brands, LP (VPRB).

VPR Brands LP (OTC:VPRB) today announces its placement in an editorial published by CannabisNewsWire ("CNW"), a multifaceted financial news and publishing company for private and public entities in the cannabis industry. To view the full publication, titled "Surging Vape Market Propels Smart Brands Growth," please visit: http://cnw.fm/r6yxQ.

Florida-based VPR Brands, LP (VPRB) is an innovative technology holding company whose assets include patented atomization-related products and technology. VPR Brands' current lineup of products includes accessories and vaporizers for cannabidiol (CBD), cannabis concentrates and extracts. The company is also engaged in product development within the vaping market and partners with top international brands to elevate their products within the vaping industry.

VPR Brands employs a growth strategy centered on high-performance, high-quality products that build exponential brand equity, awareness and loyalty. The company's current product portfolio is comprised of the following:

  • GoldLine combines premium ingredients and extracts coupled with the newest in technology to achieve the ultimate selection of cannabidiol (CBD) and hemp-based products available anywhere. The product range is designed for a wide variety of consumers and features edibles such as gummies and pure honey stix, tinctures, pre-rolled flower, vapable products and creams. For more information please visit?www.cbdgoldline.com.
  • HoneyStick is a lifestyle brand that combines the features of high tech, high performance, dependability and affordability when it comes to upper tier vaporizers. HoneyStick was first to market in creating a Sub Ohm vaporizer to the latest Ripper and Plasma GQ. The HoneyStick team works with a vast network of growers, extractors and industry figures to bring the needs of patients and recreational users to life. HoneyStick is sold online and through a diverse network of distributors, e-tailers, dispensaries and smoke shops. For more information about HoneyStick, visit?www.vapehoneystick.com.
  • Helium brings the vaping experience to a new level with intense flavors that are steeped to perfection and chilled at 20 degrees below room temperature. Helium's chillers are scientifically proven to preserve flavor, freshness and aroma. Helium is in a 50ml durable and squeezable bottle with drip tip that is functional from the start, engineered to deliver 77 percent VG.
  • Vaporin delivers Sub Ohm series starter kits. Vaporin also provides an eye-catching display case with multi-packs of selected starter kits, coils and premium e-liquids for retail and dispensary operations.
  • Vaporx offers the most current, highest quality products from the best-known brands, including KangerTech, eLeaf, Aspire, Pioneer4You, JoyeTech, Samsung. Vaporx acts as an extension to a client's purchasing department, providing the option to schedule regular product mix refresh for maximum sales.
  • GoldLine Hemp products are developed specifically for the convenience store market segment. GoldLine Hemp-only products are created without CBD, providing an alternative product line for consumers who are not ready to experience CBD products but still want to take advantage of this rapidly expanding class of products. GoldLine Hemp-only edible Hemp Gummies debuted at the National Association of Convenience Stores (NACS) Expo in Las Vegas in October 2018 and are now being distributed nationwide. The U.S. convenience store industry, with more than 154, 000 stores nationwide, serves 160 million customers daily and has sales that are 10.8% of the total U.S. retail and food service sales. Visit?www.goldlinehemp.com?for more information about GoldLine Hemp-only products.
  • Vapor Store Direct in Fort Lauderdale, Florida, is one of the largest vaporizer and e-liquid wholesalers in the United States. Vapor Store Direct stocks internationally elite brands, vaporizers, tanks/atomizers, coils, e-liquid, e-cigarettes, batteries, glass and accessories.

Management Team

CEO Kevin Frija is a veteran entrepreneur with nearly 30 years of experience in sourcing, manufacturing, supply chain management, marketing, advertising and brand licensing. In 2009, Frija became the president and chief executive officer of Vapor Corp., one of the first U.S. importers and publicly traded electronic cigarette companies. In 2016, Frija purchased the brands and wholesale business assets from Vapor Corp., which is now owned by VPR Brands. Under his leadership, VPR Brands is pivoting toward cannabis products which is increasing sales and profit margins.

Dan Hoff, chief operating officer, has worked in the vaporizer and e-cigarette industry, serving in various positions at Vapor Corp., including overseeing the financial management, accounting functions, supply chain management, product design and development, and key vendor relations. He has played a pivotal role in building and expanding the cannabis-based products division at VPR Brands, which includes a turnkey OEM vapor solutions program available to farmers, cultivators and extractors. Hoff received his bachelor's degree from the University of Miami School of Business.

VPR Brands, LP (VPRB), closed the day's trading session at $0.0663, off by 1.04%, on 5,800 volume with 9 trades. The average volume for the last 3 months is 84,372 and the stock's 52-week low/high is $0.026/$0.14.

Recent News

chart

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

ActionStockPicksAgressive StocksBetting On Wall StreetCannabisNewsWireGot Stocks?Got Stock Tips?Green Car StocksGreen Energy StocksGreen On The StreetHomeRunStocksMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireQualityStocks MediaQStocksQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsStock BeatsStocks To Buy NowTerrificStocksTiny GemsTip.usTouchdownStocksDaily ToutTraderPower

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.